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Nearly 80% of patients undergoing maintenance hemodialysis have some degree of volume 
dependent hypertension, which contributes to poor quality of life, cardiovascular morbidity, and 
mortality. Despite routine dialysis and pharmacological treatment, chronic volume overload has 
remained a challenging problem in hemodialysis. Dietary sodium restriction is a critically 
important strategy for preventing volume overload, yet has not been the focus of routine clinical 
counseling or research interventions. This is likely because there are significant barriers to 
following a low sodium diet, which have contributed to the poor efficacy of dietary counseling to 
reduce sodium intake in the renal nutrition literature. Home delivery of low-sodium meals is an 
alternative to low-sodium counseling that bypasses many of the barriers to reducing sodium 
intake and reducing acute volume overload. This approach has been shown to reduce sodium 
intake and improve cardiovascular function in individuals with hypertension and heart failure. 
However, there are no studies to date examining the effects of low-sodium home delivered meal 
provision in hemodialysis patients. Recent studies have suggested that dietary sodium may 
accumulate within tissues and that excess tissue sodium has been associated with markers 
cardiovascular risk. No research has investigated the relationship between diet and tissue sodium 
or whether sodium restriction can reduce excess tissue sodium accumulation. Meal provision 
represents a feasible method to reducing sodium intake, tissue sodium, and measures of volume-
dependent hypertension that could eventually be evaluated for long-term efficacy, cost-
effectiveness, and clinical outcomes. The objective of this dissertation is to examine the efficacy 
of dietary strategies and interventions for reducing dietary sodium intake, with a special 
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CHAPTER 1: INTRODUCTION 
 
Cardiovascular disease (CVD) is the major cause of death in patients with renal failure 
undergoing maintenance hemodialysis (HD) therapy.1 This is due in part to the high prevalence 
of chronic volume overload (VO), which leads to hypertension, left ventricular hypertrophy, and 
congestive heart failure.2–4 VO also contributes to poor patient quality of life manifested by 
edema, fatigue, impaired breathing, and poor dialysis treatment tolerance.5 Hypertension is 
primarily treated using antihypertensive medications, but these typically do not address their 
underlying VO that is causing the problem.6,7 Moreover, dialysis therapy has limited efficacy to 
treat VO.6,8,9 Dietary sodium intake and retention are major contributors to volume-dependent 
hypertension in HD patients.10,11 Specifically, a high sodium diet is associated with excessive 
fluid intake and interdialytic weight gain (IDWG), leading to chronic VO and subsequent 
hypertension.12,13  
Recent research has uncovered a new mechanism by which sodium may also impact 
CVD risk. In controlled sodium balance studies, it was discovered that dietary sodium may be 
temporarily stored in soft tissue such as the skin and skeletal muscle.14 Excessive sodium 
accumulates within the interstitial space. This activates a localized immune response that 
promotes vasodilation and the expansion of lymphatic vessels that mobilizes sodium back into 
the recirculation for excretion, thus serving as a novel sodium buffering mechanism.15–17 In aging 
and certain chronic diseases like diabetes and renal failure, there appears to be dysregulation of 
this mechanism characterized by deficient lymphatic expansion, vasoconstriction, and excessive 
tissue sodium retention.18 Tissue sodium levels are positively correlated with hypertension and 
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left ventricular hypertrophy, so this reservoir may be an important therapeutic target.19,20 
Surprisingly, few studies to date have investigated whether reducing dietary sodium can reduce 
tissue sodium accumulation. 
HD patients are often counseled to reduce dietary sodium intake to reduce their thirst, 
which should in turn reduce IDWG, chronic VO, and hypertension.10,13,21 Unfortunately, 
strategies to reduce sodium intake in HD patients are often unsuccessful.12 Low-sodium trials in 
HD are sparse and mostly indicate that dietary education and behavioral counseling are 
ineffective in reducing sodium intake.22–27 Dietary sodium and fluid intake are dependent on 
patient dietary behaviors and clinicians often lack the time and resources to provide adequate 
counseling to effectively manage this problem.28,29 These challenges indicate that novel 
approaches may be needed to promote sustained changes in dietary behavior to reduce sodium 
intake and VO.  
An alternative dietary approach, the efficacy of which has recently been evaluated in 
patients with both hypertension and chronic heart failure, is home meal delivery.30 In addition to 
providing potential short-term benefits, brief periods of home-meal delivery may help prime 
longer term behavior change, though the efficacy of this approach for promoting dietary change 
in dialysis patients has not been evaluated. The overall objective of this dissertation is to examine 
strategies and interventions to reduce dietary sodium and improve VO among patients on HD. In 
the core trial we examine the effects of four-weeks low-sodium, home-meal delivery on factors 
related to volume-dependent hypertension, and muscle sodium accumulation in HD patients. We 
additionally evaluate the dietary patterns, knowledge, and barriers to following a low-sodium 




CHAPTER 2: LITERATURE REVIEW: THE RATIONALE FOR RESTRICTING 




Chronic volume overload is a persistent and challenging problem in kidney failure patients 
undergoing chronic hemodialysis (HD) therapy. Volume overload is defined as an expansion of 
the extracellular fluid compartment, but is rarely quantified in an objective manner. Some 
estimates suggest the prevalence of volume overload exceed 40-60%% ,7,31–33 but this estimate is 
uncertain since there is no universal standard diagnosis for volume overload diagnosis in either 
clinical practice or research.34 Chronic volume overload contributes to a poor quality of life, 
caused in part by edema, fatigue, impaired breathing, and poor dialysis treatment tolerance.35 
Volume overload also contributes to hypertension and left ventricular hypertrophy, which are 
leading causes of morbidity and mortality in HD patients.5,36–38  
Volume overload and hypertension are managed through a combination of pharmacological 
therapy, dialysis therapy, and lifestyle modifications that include dietary sodium restriction.39 
Dietary sodium intake, which stimulates thirst and subsequent fluid intake, is a primary cause of 
volume overload in HD patients.10 However, antihypertensive medications are typically the first-
line approach for treating hypertension aside from the prescribed dialysis treatment.6 This is 
perhaps because modifying patient’s dietary sodium and fluid intake demands behavioral 
intervention strategies that require more effort than most clinicians are able to provide.28 
Nonetheless, dialysis providers recognize the need to focus on reducing chronic volume overload 
to improve morbidity and mortality rates in HD patients.40 The limitations of pharmacological 
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and dialysis therapy make sodium restriction critical to prevent and treat volume overload and 
hypertension.41 
Seminal work in the U.S. from the 1960’s,42–45 as well as more recent studies in Tassin, 
France46 and Izmir, Turkey47 have shown that blood pressure can be controlled in many HD 
patients non-pharmacologically, using comprehensive volume control strategies that include 
significant restrictions in dietary sodium intake (e.g., < 2000 mg/day) in conjunction with 
progressive ultrafiltration and reduced reliance on antihypertensive medications.7,48 These data 
suggest that sodium restriction is key to successful volume control and improving patients’ 
quality of life and clinical outcomes. Indeed, pharmacotherapy or altering dialysis parameters 
(e.g., increasing ultrafiltration rate and reducing dialysate sodium) have shown limited efficacy 
in treating volume overload when not coupled with sodium restriction.47,49–51 Unfortunately, non-
pharmacological approaches to managing volume and hypertension in HD patients do not appear 
to be the primary focus of clinical practice today.52 
One likely reason that comprehensive volume control protocols are not widely practiced 
is because it is challenging to reduce dietary sodium intake, a vital component of volume control. 
Low-sodium dietary trials in HD are sparse and mostly indicate that dietary education and 
behavioral counseling are ineffective in reducing sodium intake and interdialytic weight gain 
(IDWG).12 These research gaps suggest that new strategies for reducing dietary sodium intake 
are needed. One sodium reduction strategy that has shown promise in patients with 
hyperlipidemia, hypertension, and heart failure is providing patients low-sodium, home-delivered 
meals.30,53,54 These comorbidities are often prevalent in patients on HD, which furthers the 
rationale for translating this approach to HD. However, studies have not widely evaluated the 
efficacy of this approach to reduce sodium intake in HD patients.  
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Another reason to reduce excess sodium consumption is to potentially reduce sodium 
accumulation in soft tissues. Recent evidence suggests that sodium levels in the skin and skeletal 
muscle of HD patients is elevated compared to healthy controls,55,56 and this may also contribute 
to cardiovascular complications including hypertension, left ventricular hypertrophy, and 
congestive heart failure.19,20 Although tissue sodium may be reduced to some extent during 
dialysis,56 no study to date has investigated whether reducing dietary sodium intake can 
chronically reduce tissue sodium storage in HD patients. Reduction of dietary sodium intake 
through low-sodium, home-delivered meals could potentially reduce tissue sodium accumulation 
and improve chronic volume overload, both factors which have been associated with 
hypertension and left ventricular hypertrophy. Importantly, home-meal delivery could bypass 
many of the barriers associated with a low-sodium diet in HD patients. Home delivered meals 
also have the potential to be formulated to be low in phosphorus and potassium, which could 
have secondary benefits in the context of the highly complex renal dietary restrictions.57 The 
objective of this review is to critically evaluate current strategies to improve volume overload 
and propose low-sodium home-meal delivery as a novel method to reduce volume-dependent 
hypertension, muscle sodium accumulation, and related factors that could impact patient quality 
of life. 
Rationale for Sodium Restriction as the Primary Focus of Volume Control 
The prevalence of volume overload is difficult to determine as clinical assessment relies 
on different subjective, objective, and proxy measures of volume status.40 However, clinicians 
may estimate acute or chronic volume status primarily through IDWG, estimated dry weight, and 
physical examination.58–60 Studies using bioelectrical impedance spectroscopy have 
demonstrated that patients with a relative volume overload of >7% may be sub-clinically 
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overhydrated and those with a volume overload of >15% may be severely overhydrated, which 
may be underestimates of the true extent of volume overload.33 Chronic volume overload 
assessed by bioimpedance spectroscopy is a risk factor for increased mortality.61 Unfortunately, 
bioelectrical impedance spectroscopy, as well as other objective methods of volume assessment 
are often unavailable or impractical to use consistently to assess volume overload in clinical 
settings.35 Despite the difficulty in quantifying volume overload, IDWG is arguably a highly 
informative and practical measure of fluid intake and retention (i.e., acute volume overload) in 
clinical practice.62  
For some HD patients, weekly fluid intake may exceed the fluid removed during their 
thrice weekly dialysis sessions resulting in chronic volume overload.63 Some patients are unable 
to remove excessive quantities of fluid, depending on their vascular refilling capacity,64 without 
experiencing cramping, intradialytic hypotension, or other cardiovascular events.65 To limit 
volume overload, HD patients are often advised to reduce both their sodium and fluid intake.66 
However, adherence with these recommendations are low.67 There are ethical concerns and 
clinical consequences with advising patients not to consume fluid when thirsty, such as 
xerostomia (dry mouth) and periodontal disease.68 Some researchers have gone so far as to 
criticize fluid restrictions as ineffective and inhumane,8,62 and suggest instead that sodium 
restriction should be the central focus of volume reduction strategies.  
This ideological shift could be based on the rationale that dietary sodium intake is a 
driver of thirst, fluid intake, and fluid retention.69 Sodium is the most abundant cation in blood 
plasma among the electrolytes, thus a major determinant of extracellular fluid osmolality and 
mobilization.70 Sodium osmoregulation is coordinated through increasing or decreasing thirst 
and concentration or dilution of urine.71 A major consequence of kidney failure is the inability to 
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concentrate and produce urine to remove both fluid and electrolytes, leaving thirst as the major 
osmo-regulatory mechanism, which is indeed higher in HD patients compared to healthy 
controls.72 Studies by Kusaba et al.73, and Kim et al.74, have demonstrated that those with kidney 
disease generally have less sodium taste sensitivity, (i.e., less able to recognize salty tastes) than 
healthy controls. Osmolytes other than sodium, such as urea and glucose, may also drive 
excessive thirst, and studies have shown that patients with diabetes on HD have greater thirst 
than those without diabetes.75 Both xerostomia and thirst have been positively associated with 
IDWG.76,77  
Tissue Sodium as an Intermediate Reservoir 
Traditional physiology teaches a two-compartment fluid and sodium model, whereas 
more recent mechanistic studies15,16,78–80 and long-term feeding studies14 suggest a novel and 
more complex model. These studies revealed that: 1) dietary sodium intake is not consistent with 
24-hour urinary sodium excretion;14,81 2) sodium may accumulate non-osmotically in 
tissues;19,55,78,79 3) tissue sodium is regulated at the bio-molecular level;15,16,80 and 4) there may 
be adverse health consequences related to excess tissue sodium accumulation.19,20,56,82 Long-term 
feeding experiments took advantage of simulated space environments where salt intake could be 
tightly controlled at fixed levels over the course of a month (12 g, 9 g, and 6 g of salt per day), 
while fluid and urine output were continuously and accurately assessed.14 A surprising finding 
from these studies was that during each month of fixed dietary sodium intake, 24-hour urine 
sodium concentrations varied significantly.14 This suggests that urinary sodium excretion is 
highly variable at fixed sodium intakes and that 24-hour urine sodium excretion is a poor proxy 
of sodium intake.83 Indeed, subsequent analyses have demonstrated multiple 24-hour urine 
collections are needed to accurately estimate dietary sodium intake.81 These findings led to a 
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novel hypothesis that dietary sodium must accumulate in body tissues, at least transiently, prior 
to being excreted in the urine.83,84  
To help examine this hypothesis, sodium-adapted MRI (23Na-MRI) technology was 
utilized to quantify tissue sodium levels.55 23Na-MRI has demonstrated that sodium can 
accumulate in various tissues, particularly in the skin and skeletal muscle.19,55 Furthermore, 
recent studies indicate that extracellular sodium can accumulate within interstitial spaces in a 
manner distinct from the conventional free sodium in interstitial fluid.15 This sodium is non-
osmotically bound within proteoglycan networks consisting of glycosaminoglycan polymers 
(Figure 2.1).79 Glycosaminoglycan structures are naturally anionic and may complex cationic 
sodium molecules in a manner where sodium is unable to exert a direct osmotic effect.80 Overall, 
it appears that a high sodium environment/accumulation stimulates local macrophages to 
upregulate signaling cascades that stimulate hyperplasia of lymphatic vessels as well as 
endothelial nitric oxide release in blood vessels to promote vasodilation.16 The end result is 
vasodilation and lymphatic expansion to mobilize both fluid and electrolytes throughout the body 
while clearing sodium storage reservoirs.85  
 Recent studies indicate that tissue sodium accumulation is positively associated with age, 
diabetes, blood pressure, and left ventricular hypertrophy.19,20 Thus, it appears that tissue sodium 
may be linked to both volume overload and hypertension. In kidney failure, non-osmotic sodium 
regulation may be the sole remaining buffering mechanism for dietary intake and 
homeostasis.84,85 Thus, extra-renal storage and regulation provides further rationale for limiting 
exogenous sources of sodium and attenuating tissue sodium accumulation. To date, however, 
few studies have examined the relationship between tissue sodium levels and clinical outcomes 
in HD patients. A recent study by Dahlmann et al.56 demonstrated that HD patients have 
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excessive sodium in their skin and skeletal muscle when compared to age-matched healthy 
controls. This study also reported that HD treatment may acutely reduce tissue sodium levels by 
19 – 27%.56 Studies have generally not yet examined the impact of diet or reduced sodium intake 
on tissue sodium storage. Currently, there is an unclear relationship between tissue sodium 
accumulation and other factors impacting HD patient’s excessive cardiovascular disease risk, 
including hypertension, chronic volume overload, arterial stiffness, and systemic inflammation. 
Management of Volume Overload in HD 
Pharmacological and Antihypertensive Agent Therapy 
Although HD patients may consume excess dietary sodium and fluids, the primary 
antihypertensive treatment strategy in HD patients is often pharmacological therapy.86 
Unfortunately, blood pressure medications may do little to curtail sodium and fluid intake in 
patients on HD.87 An additional concern is that these pharmacological interventions could mask 
or exacerbate underlying volume overload by impacting thirst, xerostomia, and other 
mechanisms.88 Research suggests antihypertensive therapy alone often provides only modest 
reductions in blood pressure and cardiovascular morbidity and mortality in HD patients.89,90 
However, polypharmacy is a highly prevalent problem in HD. Some studies indicate patients are 
prescribed on average at least 10 different medicines totaling nearly 20 pills per day,91 with 
antihypertensive medications accounting for nearly 20% of the total pill burden.92 This 
abundance of prescribed medications in patients undergoing dialysis also contributes to 
hospitalizations, admissions, morbidity, and mortality.93 Thus, it is not surprising that more than 
half of patients undergoing dialysis have poor medication compliance.92 Polypharmacy increases 
drug interactions, and many antihypertensive agents also increase the risk of hemodynamic 
instability during treatment, especially intradialytic hypotension.6,94 Intradialytic hypotension 
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may force shortened HD treatments to prevent worsening symptoms, thus lead to further fluid 
retention and poorer volume status, which may worsen cardiovascular outcomes.95  
Altering the Dialysis Treatment Prescription  
Chronic volume overload can be managed to some extent through modifications to 
dialysis-related parameters, including the dialysate sodium composition or ultrafiltration rate, 
duration, and frequency. These modifications must balance the rate and volume of fluid removal 
with patient symptoms such as intradialytic hypotension and cramping.96,97 Occasionally HD 
patients may require additional treatments, but medical reimbursement and facility capability 
may be limited in this capacity.98 In addition, patients undergoing routine HD may poorly 
tolerate aggressive ultrafiltration strategies intended to reduce excess volume.99 The side effects 
of aggressive dialysis include intradialytic hypotension, which is associated with increased 
cardiovascular events and mortality.100,101 Hypotensive events may result in shorter dialysis 
treatment times and/or the therapeutic administration of saline solution, which may increase 
thirst and cause further fluid accumulation.102 Aggressive ultrafiltration in this manner may 
create a cycle leading to excessive fluid retention and worsening of volume-dependent 
hypertension.  
Reduction of fluid volume in dialysis is dependent on the management of estimated dry 
weight, which is dependent on both previous volume status and IDWG.103 Estimated dry weight 
is a subjective measure of volume status and may not accurately represent true euvolemia in 
dialysis patients.40 Regardless, estimated dry weight remains the primary clinical representation 
of euvolemia and may be better elucidated and achieved with objective measures such as 
bioimpedance and relative blood volume monitoring.104,105 However, the benefits of relative 
blood volume monitoring are unclear and have yet to demonstrate efficacy in reducing volume 
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and improving patient outcomes in large-scale clinical trials.106,107 Dialysis facilities are limited 
in both time and resources to not only properly assess estimated dry weight, but to also 
effectively reach dry weight goals, especially when patients are routinely and grossly 
overhydrated.108 Furthermore, many facilities do not have clear policies in place for managing 
volume overload.109 Patients may cramp or experience other hypotensive symptoms during a 
dialysis treatment due to inadequate vascular refilling and rapid ultrafiltration rates, not 
necessarily because euvolemia has been reached.95,110,111  
One inherently simple strategy to reduce volume overload and hypertension is to simply 
increase ultrafiltration volume to reduce post-dialysis weight. However, this may have 
deleterious consequences, as evidenced in the Dry-Weight Reduction in Hemodialysis Patients 
(DRIP) trial.50 In this study, patients were randomized to usual care or intensive ultrafiltration to 
reduce post-dialysis weight by 0.1kg/10 kg body-weight loss for 8 weeks. The primary finding 
was that the intensive ultrafiltration group indeed demonstrated greater reductions in systolic 
blood pressure (SBP) compared to controls at both 4 and 8 weeks (-6.9 mmHg SBP and -6.6 
mmHg SBP, respectively). However, hypotensive events were increased significantly in the 
intensive ultrafiltration group. Dietary sodium was not a target of the intervention, so IDWG was 
not reduced. This trial demonstrates that in the absence of dietary sodium restriction, it is not 
only difficult to control hypertension by increasing ultrafiltration rates, but it is potentially 
dangerous, as doing so may ultimately lead to intradialytic hypotension, cramping, post-dialysis 
fatigue, and myocardial stunning, a potentially fatal complication caused by intermittent 
ischemia to the cardiac muscle.95,112  
A similar approach was implemented in the Blood Pressure in Dialysis (BID) Study, with 
a focus on blood pressure medication management.49 In this trial, the intervention protocol was 
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based on a standardized dialysis unit SBP measurement target arms of 110-140 mmHg 
(intensive) or 155-165 mmHg (standard of care). BID primarily focused on the feasibility and 
safety of an intensive blood pressure control arm versus standard care over 12 months. 
Individuals in the intensive blood pressure control arm experienced significantly increased 
hypotensive events, cardiovascular events, hospitalizations, and mortality.49 Other studies have 
demonstrated similar results of intensive ultrafiltration on outcomes of weight, blood pressure, 
and hypotensive events.113–115 Due to concerns for hypotensive events and poor outcomes, 
ultrafiltration rate was established as a process measure in dialysis facilities (13mL/kg/hr).116 
Indeed, evidence suggests that mean ultrafiltration rates are decreasing but cardiovascular-related 
hospitalizations may be rebounding upwards in the last decade.117,118 This is a counterintuitive 
finding, but is suggestive that patients are becoming more overhydrated as a consequence of 
these practices. 
Because varying dialysis intensity or duration has numerous complications or drawbacks, 
reduction of dialysate sodium is also proposed as a method to reduce IDWG and blood pressure. 
Several small trials and some epidemiological data suggest that dialysate sodium is positively 
associated with IDWG and blood pressure.119,120 However, studies that have altered dialysate 
sodium, through alignment or profiling methods, have not demonstrated significant 
improvements in volume status or patient outcomes in dialysis.121,122 One large, long-term trial is 
currently investigating the impact of dialysate sodium on cardiovascular outcomes.123 Over the 
last several decades, studies have shown that both the reduction of dialysis duration and an 




Efficacy of Sodium Restriction as Part of Comprehensive Volume Control 
While it appears that isolated interventions aimed at reducing dietary sodium intake in 
HD have had limited success,52 some studies have demonstrated success when sodium restriction 
has been included as part of a more comprehensive volume control intervention strategy that 
includes stringent management of ultrafiltration rates and reduced reliance on BP medications 
(Table 2.1).124–126 Dialysis centers in Tassin, France have long practiced strict sodium restriction, 
which appears to result in better patient outcomes in comparison to the U.S.124 Tassin Centers 
had nearly 50% reduced mortality rates and lower IDWG, volume overload, and blood 
pressure.125,126 However, a caveat to the Tassin approach is the coupling of low-dietary sodium to 
eight-hour HD therapy.  
By contrast, dialysis centers in Izmir, Turkey adopted a similar strategy, albeit with thrice 
weekly, 4-hour HD, as is common in the U.S.47 Despite the reduced dialysis treatment times, 
they are able to achieve similar results, including normal blood pressures without 
antihypertensive medications in up to 95% of patients.7,9,24,87,127 One example of this was a cross-
sectional comparison of two dialysis clinics in Turkey conducted by Kayikcioglu et al.24. One 
center controlled blood pressure using a comprehensive volume control strategy that included 
intensive ultrafiltration and dietary sodium restriction, while the second center controlled blood 
pressure with antihypertensive medications. Both centers had improvements in blood pressure, 
but the comprehensive volume reduction strategy significantly reduced IDWG, hypertension, and 
left-ventricular mass index. 
Notably, both Tassin and Izmir achieve significant reductions in blood pressure without 
antihypertensive medications in the majority of patients.87 Comprehensive volume reduction 
strategies, combining sodium restriction and increased ultrafiltration, are not novel and were 
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originally recommended in the early decades of dialysis.42–44 However, there are few examples 
outside of Izmir and Tassin where this approach is being successfully applied today. Raimann et 
al.128 conducted a pilot volume control intervention in the U.S., modeled after the Izmir protocol. 
While they showed reductions in IDWG and blood pressure, this study was only published in 
abstract form, so the results should be interpreted with caution. Unfortunately, these studies are 
also lacking data on important clinical outcomes such dietary intake and calculated volume 
overload. We also conducted a pilot volume control intervention that included dietary sodium 
restriction.129 Our data is generally consistent with recent studies that demonstrated only modest 
changes in dietary sodium intake and IDWG in HD patients provided with weekly nutritional 
education and counseling (Table 2.1).129 Taken together, the data from Tassin and Izmir provide 
convincing evidence that dietary sodium restriction, as part of a comprehensive strategy of 
volume control, can be efficacious. Ultimately, the failure to fully replicate these findings in the 
U.S. suggest that novel strategies to reduce sodium intake are needed. 
Isolated Attempts to Manage Dietary Sodium 
Sodium restriction in HD patients is recognized as an important strategy to reduce fluid 
intake and subsequently reduce IDWG, volume overload, and hypertension.13 Many studies in 
HD patients have indicated that dietary sodium consumption exceeds recommendations, with 
intakes that typically range from 2 – 14 grams per day.22,25–27,130–133 Unfortunately, strategies to 
reduce dietary sodium intake in patients undergoing HD have had little success.12 Renal 
dietitians provide regular counseling for HD patients to reduce their dietary sodium and fluid 
intake, but patient adherence to these recommendations remains low.28,134 Several dietary 
education or behavioral interventions have not achieved or sustained significant reductions in 
both dietary sodium intake and IDWG (Table 2.2).22,25–27,133  
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For example, Sakai et al.27 reported modest changes in IDWG to dry weight ratio, 
estimated sodium intake, and estimated water intake following long-term nutritional counseling. 
However, this study was conducted in a sequential 48-month observational followed by 48-
month intervention period, with primary findings reported by individual paired t-tests. The 
clinical significance of the reported ratios or the statistical significance of unadjusted multiple 
comparisons in this study are unclear, as final sodium intake was not less than baseline sodium 
intake. Sevick et al.26, conducted the largest randomized clinical trial (RCT) to date to attempt to 
reduce dietary sodium intake in HD patient with behavioral counseling. Unfortunately, this trial 
found no differences in dietary sodium intake or IDWG at 8 or 16 weeks. The study group has 
since concluded that there are ample dietary barriers to change in patients undergoing HD, which 
may have contributed to these findings.29,135,136 In a smaller RCT, Rodriguez-Telini et al.25 
demonstrated reductions in dietary sodium intake in their nutritional counseling group and no 
dietary change in the control group. These results were not accompanied by reductions in IDWG. 
Maduell et al.133 and Rigby et al.22 were two small studies that demonstrated successful 
reductions in both dietary sodium intake and IDWG, yet neither has been published as a full-text 
original article (i.e., short communication and abstracts only). Importantly, Rigby et al.22 
provided a strict shopping list, daily diet plan, and provided low-sodium foods throughout the 
intervention to increase adherence. Epidemiological data suggests that IDWG is positively 
associated with both sodium intake and poor health outcomes, yet few trials have successfully 
managed to reduce dietary sodium consumption in patients undergoing dialysis.137–140 Thus, 
there is a critical need to develop strategies to support reduced sodium intakes and subsequent 
reductions in IDWG to improve volume overload and reduce cardiovascular mortality. 
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Rationale for Providing Home-Delivered Meals to Hemodialysis Patients 
HD patients face a plethora of barriers that make it extremely challenging for them to 
adhere to recommendations to significantly restrict their dietary sodium intake.10,29,62 Commonly 
cited barriers include time constraints and fatigue related to dialysis treatments,29 and 
socioeconomic factors, such as food cost and availability (Table 2.3).141 Many HD patients may 
also lack cooking equipment and/or have physical limitations that reduce their ability to cook 
their own food.29 Poor nutrition and health literacy, an inability to track nutrients, and feelings of 
deprivation also contribute to low adherence with the renal diet.29,142 Given all these barriers, it is 
clear why attempts to restrict dietary sodium intake through enhanced education and counseling 
alone have had limited success (Table 2.2).22,25–27,133 By contrast, providing home-delivered 
kidney-friendly meals may help mitigate many of the barriers to eating a low-sodium diet.  
Evidence from Other Clinical Populations 
Low-sodium meal provision has shown promise in patients with hyperlipidemia, 
hypertension,53 and heart failure.30 Troyer et al.53 provided seven home-delivered meals per week 
for 12 months to older adults with cardiovascular disease. The primary finding by was that 
providing meals adopting the Dietary Approach to Stop Hypertension (DASH) diet increased 
DASH accordance (adherence), indicating that this was both a feasible and efficacious approach. 
In patients with heart failure, Hummel et al.30 randomized patients to usual care or three DASH 
meals per day for 4 weeks to post-discharge patients with heart failure. Meal provision in this 
study appeared to improve survey-evaluated clinical status, rate of re-hospitalizations, and 
duration of re-hospitalizations. Kalogeropoulos et al.54 randomized patients with heart failure to 
1,500 or 3,000 mg sodium home-delivered meals in a similar manner but for 12 weeks. The 
primary finding of this study was that the meals were generally well tolerated without adverse 
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safety or quality of life signals. Overall, these studies suggest that providing meals may be a 
practical method to achieve dietary adherence that may also translate to improved clinical 
outcomes in clinical populations. Both Hummel et al.30 and Kalogeropoulos et al.54 used the 
commercial vendor PurFoods, LLC (Ankeny, IA, www. purfoods.com), which also provides 
meal options for patients on HD. We have conduct one pilot trial in HD, with a similar home-
delivered approach where participants had generally good meal adherence and improvements in 
some clinical outcomes such as IDWG, volume overload, and BP.143  To date, however, no 
studies have generally not investigated the efficacy of a controlled feeding approach to manage 
sodium intake in HD patients. 
Clinical Benefits 
In addition to helping overcome barriers to a low-sodium diet, home-delivered meals also 
could yield clinical benefits specifically relevant to HD patients (Figure 2.2). First, reducing 
sodium intake could reduce thirst, sodium, and fluid retention. This decrease in thirst may in turn 
lead to reduced IDWG, volume overload, and hypertension, which may translate into reductions 
in left ventricular hypertrophy, congestive heart failure, and cardiovascular mortality. Second, 
reductions in IDWG may reduce complications from dialysis such as intradialytic hypotension, 
cramping, and fatigue, which may improve patient quality of life. Moreover, a low-sodium diet 
may also reduce tissue sodium levels and thus further reduce cardiovascular risk in HD patients. 
Some commercial vendors30,144 also provide kidney-friendly meal options that are low in 
potassium and phosphorus; therefore, home-delivered meals may also help prevent hyperkalemia 
and hyperphosphatemia, through reduction of highly bioavailable phosphate and potassium 
additives. These meals can also be formulated to provide both consistent and adequate energy 
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and protein intake to promote reductions in protein energy wasting. Similarly, diabetes- and 
heart-healthy options may be available for patients with these comorbidities. 
Concerns and Costs 
There are also a number of concerns with home-delivered meals that need to be 
considered. One obvious concern is the up-front costs associated with providing these meals. 
Typically, most home-delivery meal services charge around $6 - $14 a meal,144,145 though this 
may vary significantly depending on the provider and/or type of meal provided. If a clinic were 
to provide two meals/patient/day, it would cost roughly $360 to $840/patient/month, which is a 
significant cost outlay for a dialysis provider or insurance agency. However, home-delivered 
meals could also provide a significant healthcare cost savings, especially if the reduced sodium 
intake helps manage chronic volume overload. Additionally, euvolemic patients may require 
fewer antihypertensive medications. Patients adhering to a kidney-friendly diet could also require 
less potassium and phosphate binders. And most significantly, reduced volume overload, 
hyperkalemia, and hyperphosphatemia should ideally lead to reduced hospitalizations.  
Three home-delivered dialysis-friendly meals would represent a minimum cost of 
approximately $587 per month.146 A cursory and proposed comparison of these costs would be 
approximately $6,000 for a cardiovascular-related hospitalization, $300 for an additional dialysis 
treatment, and under $100 per month for each pharmaceutical medication (antihypertensive 
agent, phosphate binder, potassium binder), though the costs and effectiveness of these 
treatments may be highly variable.147–153 Meal provision could in theory additionally aid with 
weight loss in patients with obesity and in turn improve eligibility for kidney transplantation, 
which would no double demonstrate significant cost-effectiveness.154 Overall, these effects could 
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also improve both quality and quantity of life, a benefit that could be desired by patients, 
healthcare providers, dialysis providers, and insurance providers alike.  
Patient Receptiveness 
Not all patients will be equally receptive to home-delivered meals, nor will meals be 
equally beneficial to all patients. An important outcome in evaluating these hypotheses will be 
which HD patients may need this service long-term versus those that may learn to change habits 
when provided low-sodium meals. Meal provision could be an effective method for “priming” 
behavior change. Priming in this context could theoretically involve providing exposure to 
environmental cues that may help modify long-term behavior. A small body of literature 
suggests that priming strategies may improve specific nutrition behaviors, but this has not been 
studied as a strategy to reduce dietary sodium intake, particularly in HD patients.155 Some 
research indicates that it may take several weeks to months on a low sodium diet to change salt 
sensitivity and preferences.156 As a result, providing home-delivered low-sodium meals for a 
short time (~ 1 to 2 months) may help facilitate long-term changes in sodium intake, and be less 
cost prohibitive. Nonetheless, it is important to investigate the mid-term and long-term efficacy, 
benefits, and cost-effectiveness of home-delivered meals as well. 
Another concern with home-delivered meals is that most commercial vendors provide 
limited meal options that are appropriate for the “renal diet”, including meals low in sodium, 
phosphorus and potassium. The limited variety of meals may not be palatable for some patients, 
may not be culturally relevant, and even if they are, meal fatigue may become an issue over time. 
Some patients may also consume significant amounts of high-sodium foods in addition to the 
home-delivered meals. However, Hummel et al.30 reported 77% overall adherence with home-
delivered meals and Troyer et al.53 also reported increased dietary accordance. Another drawback 
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is that providing meals also may not help patients learn cooking skills that will help them sustain 
these dietary changes. Conversely, meal provision could demonstrate examples of healthy or 
desired diet and lead to positive taste changes. Furthermore, the total calories and protein content 
of provided meals may be lower than recommended for HD patients. If so, these patients may 
simply require additional healthy snacks or oral nutrition supplements to meet energy and protein 
requirements, which is already common clinical practice. 
In summary, while the efficacy of home-delivered meals in patients undergoing chronic 
HD needs to be evaluated, there are a number of potential benefits that make this an intriguing 
idea to explore. If dietary sodium can be effectively controlled, it will be much easier to manage 
chronic VO, which may translate into improvements in cardiovascular-related outcomes. To 
date, most studies have failed to show that dietary education and counseling produces sustained 
changes in sodium intake in HD patients. This is not surprising, given the ubiquitous presence of 
sodium in our food supply, and the plethora of barriers that HD patients face when trying to limit 
their sodium intake. Home-delivered, low-sodium meal delivery services may help HD patients 
overcome many of these barriers. Studies need to investigate the efficacy of meal provision in 
HD to demonstrate this approach is a cost-effective and sustainable model to achieve sodium 
restriction. Importantly, low-sodium meal delivery may improve both clinical outcomes and 




Table 2.1 Comprehensive Approaches to Reduce VO and Hypertension in HD 
Author Results 
Charra et al.126 
• 98.4% BP controlled 
• 98.4% BP medication free 
• Highest global HD survival rate 
Kayikcioglu et al.24  • 82% BP controlled 
• 93% BP medication-free 
• Reduced IDWG (~1.0 kg/day)* 
• Reduced LVH (~14)*  
Ozkahya et al. 
19999 & 
Ozkahya et al. 
2002127 
• 96% BP controlled & medication free 
• Reduced IDWG (~5.1 kg/day)* 
• Reduced LVMI (~70 g/m2)* 
• Reduced CTI (~11%)* 
• Reduced hypotensive events 
Raimann et al.128 • Reduced systolic BP (16 + 5 mmHg)* 
• Reduced diastolic BP (7.2  + 2.6  kg)* 
• Reduced pre-HD weight (3.9 + 2.6  kg)* 
• Reduced post-HD weight (3.8 + 2.6 kg)* 
Perez et al. 129 • Trend for reduced 1,2 month IDWG (p=0.05) 
• Reduced EDW (mean -2.3 ± 3.9 kg)* 
• Reduced volume overload (mean -1.3 ± 1.8 L)* 
• Reduced BP medications (mean -1 ± 1)* 
• No significant BP changes (maintained) 
All included studies consisted of a low-sodium diet, progressive ultrafiltration, and conventional (4-hour) dialysis, with the exception 
of 8-hour dialysis in Charra et al.126 * Statistically significant (P<0.05). HD, hemodialysis; BP, blood pressure; LVH, left ventricular 








N Intervention Result (change) 
Effect Size 
(Cohen’s d) 
Perez et al., 
2020 Single arm, 20 
Usual-diet followed by 
low-sodium meals, 
4-weeks pre vs 4-weeks post 
Na intake Δ: -1.6 + 0.3 g/d,* 
IDWG Δ: -0.8 + 0.1 kg* 
Na: 1.71, 
IDWG: 0.53 
Sakai et al.,  
201727 Single arm, 48 
Usual-diet followed by  
counseling, 
48-months pre vs 48-months post 
Na intake Δ: -0.6 + 0.2 g/d,*† 
IDWG (kg) not reported Na:  0.60 





Counseling or  
counseling + technology support, 
16-weeks 
No Δ: dietary Na intake, 
No Δ: IDWG 
Na: 0.00,  
IDWG: 0.18  
Rodriguez- 





Usual-diet or  
Usual-diet less 2g/Na/d, 
16-weeks 
Na intake Δ: -2.5 + 0.4 g/d,* 
No Δ: IDWG 
Na: 1.92, 
IDWG: 0.24 
Maduell et al.,  
2000133 Case-control, 15 Nutritional counseling 
Na intake Δ: -1.2 + 1.2 g/d,* 








Usual-diet or  
0.5 g/Na/d, 
1 week 
Na intake Δ: -2.7 + 0.2g/Na/d,* 
IDWG Δ: -0.8 + 0.2 kg* 
Na: 3.30, 
IDWG: 0.77 
* Statistically significant (P<0.05), † within-subjects statistical comparison non-significant (P>0.05) or not reported. All values 
standardized from salt intake to Na-content. Smallest effect size reported based the lowest reported change values. Adapted from 
Bossola et al. (2018) in the Journal of Renal Nutrition.12 Na, sodium; RCT, randomized control trial; RCCT, randomized control 
cross-over trial, IDWG, interdialytic weight gain; CON, control group; INT, intervention group.  
23 
 
Table 2.3 Potential Benefits and Concerns of Home-Delivered Meals in Kidney Failure 
Benefits Concerns 
(1) Adherence and barriers: 
• Less reliance on the need for shopping and cooking  
• Improved food security 
• Promote changes in salt-taste sensitivity/preference to 
promote short or long-term behavior change 
(1) Adherence and barriers: 
• Not eating provided meals and meal fatigue 
• Consumption of high Na+ food in addition to the meals 
provided 
• Reduced cooking self-efficacy & storage requirements  
• Reduced patient autonomy for meal decisions 
• Culturally appropriate meals may not be available 
(2) Clinical benefits: 
• Reduced Na, K, P, & thirst/fluid intake 
• Reduced volume overload, HTN, hyperkalemia, 
hyperphosphatemia 
• Improved HD treatment efficacy & reduced HD adverse 
effects 
• Diabetes- and heart-healthy meals could be formulated 
(2) Clinical consequences 
• Meals may not meet entire nutritional needs: 
o Energy, protein, micronutrients 
• Need for additional oral nutritional supplements 
(3) Long-term cost-effectiveness: 
• Reduced antihypertensive medications, phosphate 
binders, potassium binders, and hospitalizations 
• Improved treatment compliance/fewer missed dialysis 
shifts 
• Safe weight reduction to improve kidney transplantation 
eligibility 
(3) Up-front costs: 
• Several hundred dollars/month/patient 
 





Figure 2.1 Tissue Sodium Storage and Regulation 
 
  
Figure 2.1: This figure depicts the novel “three-compartment” storage and regulation of tissue 
sodium. 1) Na+ cations may complex with anionic GAG within the endothelial proteoglycan 
structure. 2) Rising Na+ concentrates upregulate TonEBP for VEGF-C secretion. 3) VEGF-C 
can bind and activate on VEGF receptors to promote lymphatic hyperplasia and/or vascular 
vasodilation. Acronyms: Na+, sodium; GAG, glycosaminoglycan; TonEBP, tonicity binding 





Figure 2.2 Potential Benefits and Concerns of Home-Delivered Meals in Kidney Failure 
 
 
Figure 2.2: This figure depicts the potential clinical benefits of kidney-friendly home-delivered 
meals. Meals can be formulated to be calorie dense and high protein to prevent protein energy 
malnutrition and wasting. Low-sodium meals may reduce thirst and fluid intake to improve 
volume-dependent hypertension. Low-potassium and low-phosphorus meals could improve 
hyperkalemia and hyperphosphatemia, in turn improving cardiac alterations and bone mineral 
disorders. Acronyms: CVD, cardiovascular disease; CHF, congestive heart failure; CKD-MBD, 




CHAPTER 3: PILOT FEASIBILITY STUDY EXAMINING THE EFFECTS OF A 
COMPREHENSIVE VOLUME REDUCTION PROTOCOL ON HYDRATION STATUS 
AND BLOOD PRESSURE IN HEMODIALYSIS PATIENTS1 
 
Abstract: 
Introduction: Chronic volume overload is a persistent problem in hemodialysis (HD) patients. 
The purpose of this study was to investigate the impacts of comprehensive volume reduction 
protocol on HD patient’s hydration status and blood pressure (BP).  
 
Methods: Twenty-three HD patients (age=55.7 ± 13.3y) completed a 6-month comprehensive 
volume control protocol consisting of: 1) reducing post-dialysis weight; 2) reducing BP 
medication prescriptions; and 3) weekly intradialytic counseling to reduce dietary sodium intake 
and interdialytic weight gain (IDWG). The primary outcome was volume overload (VO) 
measured by bioelectrical impedance spectroscopy. Secondary outcomes included: IDWG, post-
dialysis weight, estimated dry weight (EDW), dietary sodium intake, BP and BP medication 
prescriptions. 
 
Findings: From baseline (0M) to 6 months (6M), significant improvements were noted in: VO 
(0M 3.9 ± 3.9L vs 6M 2.6 ± 3.4 L, p=0.003), post-dialysis weight (0M 89.4 ± 23.1 kg vs 6M 
 
1 Reprinted from Hemodialysis International, Volume 24, Issue 4, Pages 414-422, Authors: Perez 
LM, Burrows B, Chan LE, Fang HY, Barnes JL, and Wilund KR, Title: Pilot feasibility study 
examining the effects of a comprehensive volume reduction protocol on hydration status and 
blood pressure in hemodialysis patients 
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87.6± 22.2 kg; p = 0.012), and EDW (0M 89.0 ± 23.2 vs 6M 86.7 ± 22.5 kg., p=0.009). There 
was also a trend for a reduction in monthly averaged IDWG (p = 0.053), and sodium intake (0M 
2.9 ± 1.6 vs 6M 2.3 ± 1.1 g/day, p=0.125). Neither systolic BP (0M 162 ± 27 vs. 6M 157 ± 23 
mmHg, p=0.405) nor diastolic BP (0M 82 ± 21 vs 6M 82 ± 19 mmHg, p= 0.960) changed, 
though there was a significant reduction in the total number of BP medications prescribed (0M 
3.1 ± 1.1 vs 6M 2.1 ± 1.3 BP meds; p=0.003).  
 
Discussion: Our volume reduction protocol significantly improved HD patient’s hydration status. 
While BP did not change, the reduction in prescribed BP medication number suggests improved 
BP control. Despite these overall positive findings, the magnitude of change in most variables 
was modest. Comprehensive changes in HD clinics may be necessary to realize more clinically 





Cardiovascular disease (CVD) is the primary cause of death in patients with renal failure 
undergoing maintenance hemodialysis (HD) therapy. Chronic volume overload (VO) is a major 
factor in the development of CVD-related co-morbidities, including hypertension, cardiac 
hypertrophy and dilatation, heart failure, and cardiovascular mortality.5,38 The prevalence of 
hypertension in HD patients in the U.S. is as high as 86%,31 and they are prescribed an average 
of 2.5 blood pressure (BP) medications.157 This data suggests that new treatment strategies are 
needed.  
For several decades, researchers from Ege University in Izmir, Turkey have practiced a 
stringent volume control strategy involving progressive reduction of post-dialysis weight, in 
conjunction with strict control of dietary sodium intake to control thirst and intradialytic weight 
gain (IDWG). This practice consistently lowers BP, nearly eliminates the need for BP 
medications, improve indices of cardiac structure and function, and reduces mortality rates7. 
Moreover, this is accomplished using a standard 4-hour, thrice weekly HD treatment protocol. 
However, the efficacy of the Turkish volume control protocol has not been evaluated in the U.S.  
The objective of this project was to implement a comprehensive volume reduction 
protocol in HD clinics in the U.S., and examine its effect on hydration status, BP, and related 
parameters. The intervention consisted of a 6-month comprehensive volume control protocol 
including: 1) reductions in post-dialysis weight; 2) reductions in prescribed BP medications; and 
3) weekly intradialytic counseling to reduce dietary sodium intake and IDWG. Our primary 
hypothesis was that chronic VO would be reduced after 6 months. Secondary outcome measures 
included: IDWG, post-dialysis weight, estimated dry weight (EDW), BP, BP medications, 




Design and Subjects 
Patients were recruited from 3 HD clinics in central Illinois. Inclusion criteria included: 
HD treatment ≥3 days/week; dialysis vintage ≥3 months; age 20-80 years; BP > 130/85 or 
prescribed at least one BP medication. Written informed consent was obtained prior to baseline 
testing. Initially, patients were randomly assigned to two groups for 6 months: 1) Volume control 
(VC), or Volume Control + Exercise training (VCE), but due to low compliance with the 
exercise intervention, data from both groups were combined for analysis. Patients underwent 
testing on a non-dialysis day at baseline and 6 months, 18-24 hours after a previous dialysis 
session. The protocol was approved by the Institutional Review Board at the University of 
Illinois and registered with Clinicaltrials.gov (NCT02627066) on 12/10/2015.  
Intervention 
The volume reduction protocol was modeled after the strategy developed in Izmir, 
Turkey.7,87,127 The intervention included three components aimed at reducing extracellular fluid 
volume: 1) incremental reductions in post-dialysis weights (~0.1 to 0.2 kg/session); 2) reduction 
of BP medications to facilitate fluid removal and prevent intradialytic hypotension (IDH); and 3) 
counseling patients on strategies to reduce dietary sodium intake to reduce thirst and IDWG. The 
volume reduction strategy was individualized for each patient based on a variety of factors, 
including baseline BP, BP medication prescriptions and compliance, and IDWG.  
Prior to initiating the volume reduction protocol, patient’s records were reviewed to 
assess current BP, EDW, IDWG, BP medication use, and history of intradialytic symptoms such 
as IDH, cramping, and post-dialysis fatigue. In patients with IDWG consistently below ~ 3.5% 
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of their EDW, incremental reductions in post-dialysis weights (from 0.1 – 0.3 kg) were 
prescribed for each treatment. If a patient’s targeted post-dialysis weight was achieved without 
symptoms, further reductions in post-dialysis weight were ordered in successive treatments. 
These incremental reductions in post-dialysis weight were continued at the discretion of the 
patient’s nephrologist. For patients with an IDWG consistently above 3.5% of EDW, nutritional 
strategies (described below) were first employed to reduce IDWG so post-dialysis weights could 
be reduced without significant increases in ultrafiltration rates. To reduce post-dialysis thirst, the 
clinic staff (nurses and technicians) were discouraged from administering saline to patients 
unless absolutely required to manage intradialytic symptoms.  
Targeted reductions in BP medications were simultaneously implemented during the 
reductions in post-dialysis weight to facilitate fluid removal and decrease the risk of intradialytic 
hypotension.7,9 Because there is no systematic protocol for eliminating BP medications in HD 
patients, the order in which these medications were reduced or removed from each patient was 
determined by their physician on a case-by-case basis. However, the general protocol (order) for 
removal was: 1) diuretics (if residual urine output < 200 ml/24 hours); 2) alpha blockers; 3) 
vasodilators (e.g., clonidine); 4) calcium channel blockers (if not needed for heart rate control); 
5) ACE inhibitors and angiotensin receptor blockers (ARBs) and 6) β-blockers (if not needed for 
heart rate control).  
The nutritional component of the volume reduction protocol was designed to decrease 
dietary sodium intake to reduce thirst, and thus, limit IDWG. Throughout the intervention period, 
patients received simple dietary education from research and clinic staff. Education was provided 
at least once/week, under guidance of research and clinic registered dietitians (RD). The primary 
objective of the nutrition education was choosing low sodium foods, while maintaining adequate 
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energy and protein intake. This included, but was not limited to, the following: 1) Shopping for 
unprocessed foods. Education was provided on how to identify unprocessed/ “whole” foods. 
Patient’s food choices were continuously reviewed to determine where they were purchasing 
their meals, as well as types of foods being purchased. Barriers to grocery shopping and purchase 
of unprocessed food, and strategies to overcome these obstacles, were discussed. Alternative 
foods were recommended when applicable. A particular point of emphasis was to review food 
labels, with a goal of identifying products containing a sodium (mg): kcal ratio <1:1. 2) Cooking 
low-sodium meals at home. Strategies for increasing patient’s success in cooking meals at home 
were also emphasized. This included ways to improve time management for shopping and food 
preparation, resources for low sodium, kidney disease-appropriate recipes, and speaking with 
family members or caregivers about the patient’s dietary needs. 3) Limiting meals eaten away 
from the home. Participants were encouraged to decrease the frequency they ate at fast food or 
full-serve restaurants, as well as advice on selecting lower sodium options at restaurants. 4) 
Fluids. Fluid restriction per se was de-emphasized, as previous research indicates a lack of 
efficacy with this approach68. Instead, the focus was on sodium reduction as a strategy to reduce 
thirst. Patients were instructed to drink no more or less than dictated by thirst, with the 
understanding that decreasing sodium would decrease thirst and IDWG. Social drinking was 
discouraged. 5) Meal Patterns and Food Selection. In order to ensure patients were consuming 
adequate energy and protein while decreasing intake of processed foods, consistent protein-rich 
meals were emphasized, with meal skipping discouraged. Conversations focused on regular meal 
consumption, eating before and after treatment, and bringing appropriate snacks to their dialysis 
sessions to consume before, during, and/or after treatment. 
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All components of the dietary intervention were approved by the clinic RD. This 
approach involved a “liberal interpretation” of the restrictions on various nutrients and food 
groups (e.g., fruits, vegetables, nuts, legumes, whole grains, and dairy), often described by 
standard renal diet recommendations, in an effort to increase the consumption of whole rather 
than processed foods. The approach was modified as necessary for patients with 
hyperphosphatemia and/or hyperkalemia, at the discretion of the RD.  
Patient’s progress in the volume reduction protocol was reviewed and evaluated on a 
treatment-to-treatment basis by the clinic staff. Patients were removed from the active volume 
reduction protocol only if their predialysis systolic BP was consistently below 140 mmHg 
without BP medications.  
Outcome Measures: 
Hydration status 
 Patient’s hydration status was assessed using a bioimpedance spectroscopy (BIS; 
Impedimed SFB7) while the patient was sitting in their dialysis chair, immediately prior to 
receiving dialysis treatment. The BIS measurement consists of 2 electrodes each on the non-
access hand and foot and utilizes low frequency currents to estimate extracellular water (ECF), 
intracellular water (ICF), and total body water (TBW), from which VO, expressed in absolute 
(L) and relative (%) can be calculated, as described.158  
IDWG, post-dialysis weight, and EDW were recorded daily from clinic records. Average values 
for each variable were calculated from the 3 treatments prior to baseline and 3 final treatments 
for comparisons at these time points.  
Blood Pressure and Medication Use 
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Measures of pre-HD BP were recorded during each testing collection period, on a 
midweek HD treatment day. Prior to the start of HD treatment, patients had their BP measured 
on non-access arm with automated BP cuff under standardized conditions (sitting at rest for 10 
minutes prior in quiet room. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) 
were measured in duplicate and averaged. A medication prescription list was obtained from 
clinic records at baseline and at 6-months for determination of BP medication usage. Medication 
compliance checks were performed by asking patients to bring in all medications so the active 
prescriptions and number of remaining pills relative to prescription fill dates could be verified.  
Dietary Intake 
 Each patient underwent three 24-hour dietary recalls at each collection period. Recalls 
were conducted by a trained researcher based on the USDA 5-pass method with steps for 
documenting foods eaten, probing for forgotten foods or beverages, prompting for portion sizes, 
questioning for brand names, and final confirmation or the day’s intake159. This multi-pass 
approach collects a single day’s dietary intake of food, beverages, vitamins, minerals, and 
supplements. The three recalls were evaluated on a dialysis weekday, non-dialysis weekday, and 
a non-dialysis weekend day at both 0M and 6M. Each recall session lasted approximately 15 
minutes.  
Dietary recalls were conducted verbally and recorded by hand then later transferred into 
the Nutrition Data System for Research (NDSR) software (University of Minnesota) for analysis 
of macronutrient and micronutrient intake. A total of six 24-hour dietary recalls were completed. 
The nutrient intake levels for 0M and 6M were averaged to allow greater understanding of the 




Clinical treatment data were collected from the participant’s dialysis treatments, 
including IDWG, EDW, and ultrafiltration volume. These data were collected for every 
treatment throughout the study and averaged for each month of study participation.  
Nutrition Knowledge 
 Patients were evaluated on their knowledge of sodium sources and its content in various 
foods using a validated sodium knowledge questionnaire.160 
Statistical Analysis: 
 Statistical analyses were conducted using the Statistical Package for Social Sciences 
(SPSS) version 24 (Chicago, IL, USA). Due to low compliance with the exercise intervention, 
the data were collapsed across the two groups (VC and VCE) and analyzed as one intervention 
group (VC). Continuous variables were reported as mean and standard deviation. Comparison of 
pre-and post-intervention measurements was conducted using a paired sample t-test. Categorical 
data were analyzed using the chi-squared test and are reported in frequencies and percentages. 
Time series clinical monthly treatment data were analyzed with repeated measures analysis of 
variance (ANOVA). A repeated measure ANOVA was conducted to determine if changes in any 
primary or secondary outcome differed by the initial group assignment (VC and VCE). However, 
no between group (interaction) effects were found, prompting the decision to combine data from 







Seventy-five patients were recruited for the study, with 37 consenting to participate 
(Table 3.1). Fourteen elected to discontinue the study protocol before completion, reducing the 
number of participants to 23 (N =12 males, 11 females, mean age = 55.7 ± 13.3 years, 41% 
African American). Reasons for withdrawal included: relocation, transplant, extensive health 
concerns, and imprisonment (Figure 3.1). 
Hydration Status 
Patients had a significant reduction in VO at 6m compared to 0M, expressed in absolute 
volume (L) (-1.3 + 1.8L; p = 0.003), or relative (%) (- 4.2 + 7.7%; p = 0.015) terms (Table 3.2). 
This was driven by a decrease in ECF (-1.4 + 1.7 L; p = 0.001), but not in ICF (-0.2 + 2.8 L; p = 
0.731) (Figure 3.2). There were also reductions in patient’s pre-dialysis weight (-1.8 ± 3.2 kg; p 
= 0.015), post-dialysis weight (-1.9 ± 3.2 Kg; p = 0.012), and EDW (-2.3 ± 3.9 kg; p = 0.009) at 
6 months. IDWG was reduced after 1 and 2 months (p < 0.05), with a trend for an overall 
reduction across the entire 6-month period (p = 0.053, Figure 3.3).  
Blood Pressure and Medication Use 
Pre- and post- dialysis BP did not change over the course of the intervention (Table 3.3). 
However, the number of prescribed BP medications was reduced by 1.0 ± 1.4 
medications/patient (p = 0.004).  
Dietary intake and knowledge 
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There was no change in total energy or protein intake over the course of the intervention 
(Table 3.4). There was a trend for a reduction in dietary sodium intake, though this was not 
statistically significant (p = 0.125). Despite this, there was a trend for an increase in sodium 
knowledge scores (p = 0.055).  
Discussion 
The primary finding from this study was that our 6-month comprehensive volume 
reduction protocol produced modest, yet statistically significant reductions in VO in HD patients. 
Our protocol also produced significant reductions in IDWG, pre- and post-dialysis weight, and 
pre-dialysis serum sodium levels, as well as a trend for an improvement in sodium knowledge, 
but not dietary sodium intake. Although changes in sodium intake were not statistically 
significant, the observed reductions (Table 3.4) translated to a numerical decrease of 570 
mg/sodium/day (95% CI: -171 to 1312 mg/sodium/day). This substantial decrease could be 
clinically meaningful, although these data should be interpreted with caution due to the inherent 
inaccuracy of dietary recalls. In comparison, Rigby-Matthews et al.22 and Maduell et al.133 
reported approximately -2.7 + 0.2 g/day and -1.2 + 1.2 g/day reductions in sodium intake 
respectively. These reductions in sodium intake corresponded to reductions in IDWG of -0.8 + 
0.2 kg and -0.5 + 0.6 kg, respectively. Unfortunately, these studies have not been published as 
full peer reviewed journal articles and no long-term randomized control trial has shown sustained 
reductions in dietary sodium intake and IDWG12. Our volume control protocol also did not 
produce reductions in either SBP or DBP. However, blood pressure remained stable despite 
fewer BP medications. Taken together, these data suggest that our volume control protocol 
resulted in modest improvements in patient’s hydration status and BP control.  
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To our knowledge, no published studies to date have attempted to replicate Izmir, 
Turkey’s comprehensive volume reduction protocol in U.S. HD clinics. Most HD clinics around 
in the U.S. and around the world attempt to control BP primarily through pharmacological 
means. These approaches have largely failed, given the prevalence of hypertension in U.S. HD 
clinics approaches 90%.31 This high prevalence is particularly disturbing considering ~ 90% of 
patients in Izmir clinics practicing comprehensive volume control strategies have BP controlled 
without using BP medications.7,9,87,127 This is similar to the early era of HD where BP control 
was achieved without medications in approximately 90% of patients using intensive dialysis, salt 
restriction, and low dialysate sodium.7  
While our volume reduction protocol achieved significant reductions in VO, neither SBP 
nor DBP was reduced. This may have been due to the fact that the magnitude of change in VO 
was relatively small (-1.3 ± 1.8L), although expressed in relative terms, this reduced VO from 
15.9 ± 15.6% to 11.7 ± 16.2%. Chronic VO is considered clinically significant in HD patients if 
greater than 15%,161 so this suggests the reduction in VO in this study may have clinical benefit. 
Moreover, it should be noted that BP remained stable with reductions in number of prescribed 
BP medications. This calls into question the efficacy of the BP medications that were removed 
and provides evidence that BP medication de-prescribing protocols are needed.  
The volume control protocol essentially consists of three major components: 1) 
incremental reductions in post-dialysis weights; 2) gradual reduction in anti-hypertensive 
medications; and 3) restricting dietary sodium intake. These strategies need to be implemented 
simultaneously for the protocol to be maximally effective. The rationale is as follows: many BP 
medications either directly or indirectly inhibit fluid removal during dialysis, in part because 
some (e.g., vasodilators and β-blockers) prevent the normal cardiovascular responses to drops in 
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fluid volume (vasoconstriction or increases in cardiac output, respectively). As a result, patients 
who are on multiple BP medications may be more likely to have intradialytic symptoms such as 
cramping or IDH when dry weight is challenged. Thus, it is difficult to achieve EDW, much less 
gradually reduce post-dialysis weight. Indeed, previous research demonstrates that some BP 
medications may promote intradialytic hypotensive events and related symptoms.162 Moreover, 
studies attempting to reduce post-dialysis weight without reducing BP medications have 
demonstrated increases in intradialytic hypotension and related symptoms.49,50,163 By contrast, 
other studies have shown that intradialytic hypotension can be reduced if cessation of anti-
hypertensive medications is included as a component of a comprehensive volume reduction 
strategy.9,127 Restricting dietary sodium intake to limit IDWG is also a critical component of 
volume control. High IDWG necessitates high ultrafiltration rates, which subsequently causes 
IDH, cramping, saline treatments, and premature cessation of ultrafiltration. As such, the 3 major 
components of the volume control strategy need to be achieved simultaneously for the protocol 
to be effective.  
We encountered several barriers when implementing our volume control protocol, likely 
limiting the magnitude of change. The first major barrier was resistance from the clinic staff and 
patients to persistent reductions in post-dialysis weight. Clinic staff resistance was mainly related 
to logistical challenges associated with changing EDW in clinic computers. The typical standard 
approach is to set the ultrafiltration volume to meet the EDW in patient records or discuss with 
patients “how much fluid” they would like to remove. By contrast, our protocol initially included 
instruction for the nurses and technicians to set an ultrafiltration goal slightly below the previous 
dialysis session’s post-dialysis weight, but adherence to this protocol was poor. Moreover, 
patients and clinical staff were hesitant to agree to reductions, in fear of adverse symptoms. 
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Significant education for both clinic staff and patients and clinic culture changes will be needed 
to overcome these barriers.  
The second major barrier was resistance from both physicians and patients to remove BP 
medications. In general, physicians and patients were comfortable removing one BP medication, 
but rarely approve of deprescribing a second, despite few instances where BP rose after the first 
medicine was discontinued. Complicating this matter, many patients were not taking their BP 
medications as prescribed and/or clinic records of patient’s medication prescription list was 
routinely not updated and inaccurate. Stringent reconciliation of BP medications is needed prior 
to initiating this protocol, and rigorous monitoring of medications must continue. Physicians and 
patients need to be convinced of the lack of efficacy of many BP medications prior to initiating 
the protocol. Future studies should consider additional structured training with the clinic staff to 
ensure that they better understand the details of the volume control protocol and are willing and 
able to implement all of its components.  
The third major barrier was resistance from the patients to reduce dietary sodium intake. 
Despite meeting with patients on a consistent basis, most patients were reluctant to make 
significant dietary changes. This was due to a variety of factors including, but was not limited to 
poor nutrition literacy, poor self-efficacy, inadequate cooking skills, inability or unwillingness to 
go to grocery stores, reluctance to significantly change their diet because salty food is satisfying, 
reluctance to change diet because family members eat high salt food, and food insecurity. It will 
be a significant challenge to find ways to overcome these barriers. Future studies should 
incorporate qualitative data collection, such as scripted interviews or focus groups, with patients 
and their family members or other caregivers to determine how to address these barriers. 
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While there are many barriers to successfully implementing stringent volume control 
protocols, it should be noted that Izmir faced similar challenges prior to initiating their program 
in the 1990’s. At this time, hypertension rates in their clinics were similar (~ 80% of patients) to 
what is typically seen in U.S. HD clinics today.9 Further, data from the SALTURK study 
suggests that salt consumption in Turkey may be as high as 300 mmol/day (18g of NaCl), 22, 23 
which is ~ 2x higher than U.S. estimates164. Moreover, early data from Izmir suggest dietary 
sodium intake (~100 – 200 mmol/day) and IDWG (~ 3.0 kg)9 were similar to what is seen today 
in HD patients in the U.S. Despite these factors, the Izmir volume reduction protocol was able to 
reduce dietary sodium intake to ~ 50 mmol, and IDWG to < 2.0 kg. The focus of the dietary 
advice is reducing processed foods, eating out less, and consuming low sodium foods from 
grocery stores. While clearly challenging, this demonstrates feasibility if clinics consistently 
focus on a low-sodium message. This message may coincide with liberalizing the restrictions on 
certain fruits, vegetables, nuts, grains, legumes, and dairy. Until the restrictions on these foods 
for renal patients are relaxed, sodium intakes will remain high as there are limited remaining 
food choices.57 Another critical element absent from our intervention compared to Izmir is full 
clinic participation with the protocol. This warrants additional investigation on best approaches 
to overcome these obstacles. Some strategies include recruiting clinics specifically based on 
nephrologist interest and commitment to the protocol, engaging clinic staff as part of the research 
team, increasing staff education, and further evaluation of staff barriers to change.  
There were several limitations to this study. First, the study lacked a control group not 
enrolled in the volume control protocol, resulting in no way to discern the extent the results were 
influenced by non-intervention factors. Second, resistance to adherence with the intervention 
from both patients and staff resulted in significant protocol deviations. While the volume control 
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protocol is designed to be flexible and individualized based on clinical judgement and other 
factors, it is clear that a culture change will be needed in U.S. clinics for successful 
implementation. Despite significant attempts to educate the staff regarding the study, the 
intervention remained an effort conducted primarily by research personnel. The staff lacked 
incentive for participation due to other job-related obligations and improved methods of 
education and engagement are needed. This was also an unpowered pilot study, so our non-
significant findings could also be secondary to the small sample size. Lastly, we did not directly 
measure patient’s fluid consumption, so cannot say for certain that our volume reduction 
protocol resulted in reduced thirst and fluid intake. Instead, we relied on IDWG as a proxy 
measure of patients’ fluid intake. 
Conclusion 
Our comprehensive volume control intervention significantly improved HD patient’s 
hydration status, and blood pressure was maintained with a reduction in the number of prescribed 
antihypertensive medications. Despite these benefits, the magnitude of the changes were modest, 
and there was significant resistance to implementing various components of the intervention 
protocol. Strategies are needed to improve the implementation of this comprehensive volume 




Table 3.1 Baseline Patient Characteristics 
Demographics and Clinical Data (n=23) Mean (SD) or N (Percent)  
Age (years) 55.7 (13.3) 
Male (%) 12 (52.2) 
Hispanic (%) 1 (4.5) 
African American (%) 9 (40.9) 
Patients w/ Diabetes (%) 10 (45.5) 
Avg. Weight (kg) 93.6 (24.4) 
Avg. IDWG (kg) 3.15 (1.1) 




Table 3.2 Bioimpedance Spectroscopy Hydration Status Data 
Parameter Baseline (0M) Final (6M) Difference P-value Mean 95% CI Mean 95% CI Mean 95% CI  
Pre-dialysis weight, kg 92.3 81.9 102.6 90.5 80.8 100.2 -1.8 -3.2 -0.4 0.015 
Post-dialysis weight, kg 89.4 79.5 99.4 87.6 78.0 97.2 -1.9 -3.2 -0.5 0.012 
Estimated dry weight, kg 89.0 79.0 99.1 86.7 77.0 96.5 -2.3 -4.0 -0.6 0.009 
           
Pre-dialysis TBW, L 46.3 41.7 50.8 44.5 40.8 48.2 -1.7 -3.5 -0.0 0.049 
Pre-dialysis TBW, % 51.2 47.7 53.5 50.5 47.5 54.7 -0.7 -2.2 0.8 0.339 
           
Pre-dialysis ECF, L 21.9 19.5 24.3 20.5 18.7 22.3 -1.4 -2.1 -0.6 0.001 
Pre-dialysis ECF, % 47.1 45.5 48.7 45.9 43.9 47.9 -1.2 -2.4 -0.0 0.044 
           
Pre-dialysis ICF, L 24.4 22.1 26.6 24.1 22.0 26.3 -0.2 -1.4 1.0 0.731 
Pre-dialysis ICF, % 52.9 51.3 54.5 54.1 52.1 56.1 1.2 0.5 2.0 0.041 
           
Pre-dialysis VO, L 3.9 2.2 5.5 2.6 1.1 4.1 -1.3 -2.0 -0.5 0.003 
Pre-dialysis VO, % 15.9 9.1 22.6 11.7 4.6 18.7 -4.2 -7.5 -0.9 0.015 
TBW, total body water; ECF, extracellular fluid; ICF, intracellular fluid; VO, volume overload.  
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Table 3.3 Blood Pressure Data 
Parameter Baseline (0M) Final (6M) Difference P-value Mean 95% CI Mean 95% CI Mean 95% CI 
Systolic BP (mmHg) 162 150 173 157 147 167 -5 -16 7 0.405 
Diastolic BP (mmHg) 82 73 91 82 73 90 -0 -9 9 0.960 
MAP (mmHg) 109 100 118 107 99 115 -2 -4 7 0.689  
          
BP meds (#) 3.1 2.6 3.6 2.1 1.6 2.7 -1.0 -1.5 -0.4 0.003 
 BP, blood pressure; MAP, mean arterial pressure.  
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Table 3.4 Nutrition and Dietary Data 
Parameter Baseline (0M) Final (6M) Difference P-value Mean 95% CI Mean 95% CI Mean 95% CI 
Energy intake, kcal/d 1588 1117 2058 1366 1164 1568 -222 -740 296 0.383 
Energy intake, kcal/kg/d 19 12 27 16 13 19 -3 -4 4 0.381 
Protein intake, kcal/d 61 47 74 56 47 65 -5 -22 13 0.602 
Sodium intake, mg/d 2886 2190 3582 2315 1830 2801 -570 -1312 172 0.125 
Sodium intake, mg/kcal 2.0 1.6 2.3 1.7 1.5 1.9 -0.3 -0.7 0.1 0.139 
           
Serum sodium, mmol/L 138.1 136.8 139.4 135.9 133.8 138.0 -2.2 -4.3 -0.0 0.049 
Sodium knowledge, score 68 58 81 76 61 91 8 -0 17 0.055 
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Figure 3.2 Measures of Hydration Status at Baseline (0M) and Final (6M) Testing  
from Bioelectrical Impedance Analysis 
 





Figure 3.3 Monthly Averaged Interdialytic Weight Gain 
 






CHAPTER 4: PILOT STUDY TO REDUCE INTERDIALYTIC WEIGHT GAIN 
THROUGH LOW-SODIUM HOME-DELIVERED MEALS IN HEMODIALYSIS 
PATIENTS1
Abstract 
Introduction: Patients with kidney failure undergoing maintenance hemodialysis (HD) therapy 
are routinely counseled to reduce dietary sodium intake to ameliorate sodium retention, volume 
overload, and hypertension. However, low-sodium diet trials in HD are sparse and indicate that 
dietary education and behavioral counseling are ineffective in reducing sodium intake. This 
study aimed to determine if 4 weeks of low-sodium, home-delivered meals in HD patients 
reduces interdialytic weight gain (IDWG). Secondary outcomes included changes in dietary 
sodium intake, thirst, xerostomia, blood pressure, volume overload, and muscle sodium 
concentration. 
Methods: Twenty HD patients (55±12 years, BMI 40.7±16.6 kg/m2) were enrolled in this study. 
Participants followed a usual (control) diet for the first 4 weeks followed by 4 weeks of 3 low-
sodium, home-delivered meals per day. We measured IDWG, hydration status (bioimpedance), 
standardized blood pressure (BP), food intake (3-day dietary recall), and muscle sodium 
(magnetic resonance imaging) at baseline (0M), after the 4-week period of usual diet (1M), and 
after the meal intervention (2M).  
Findings: The low-sodium meal intervention significantly reduced IDWG when compared to the 
control period (-0.82 ±0.14 kg; 95% confidence interval, -0.55 to -1.08 kg; p<0.001). There were 
 
1 Reprinted from Hemodialysis International, Hemodial Int. 2020. Volume 25, Issue 2, Pages 
265-274, Authors: Perez LM, Fang HY, Ashrafi SA, Burrows B, King AC, Larsen RJ, Sutton 
BP, and Wilund KR, Title: Pilot study to reduce interdialytic weight gain through low-sodium 
home-delivered meals in hemodialysis patients 
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also 1 month (1M) to 2 month (2M) reductions in dietary sodium intake (-1687±297 mg; 
p<0.001); thirst score (-4.4 ± 1.3 p=0.003), xerostomia score (-6.7 ± 1.9 p=0.002), SBP -
18.0±3.6 mmHg, p<0.001), DBP (-5.9±2.0 mmHg, p=0.008), and plasma phosphorus -1.55±0.21 
mg/dL, p=0.005), as well as a 0M to 2M reduction in absolute volume overload (-1.08±0.33 L, 
p=0.025). However, there were no significant changes in serum or tissue sodium (all p>0.05).  
Discussion: Low-sodium home-meal delivery appears to be an effective method for improving 
volume control and blood pressure in HD patients. Future studies with larger sample sizes are 






Patients with kidney failure undergoing maintenance hemodialysis (HD) therapy have 
excessive cardiovascular co-morbidities that contribute to a poor quality of life, higher mortality, 
and excessive healthcare costs.1 Chronic volume overload is a primary driver of the 
cardiovascular comorbidities in HD, including hypertension, left ventricular hypertrophy, and 
heart failure.7 The prevalence of volume overload and hypertension in HD patients may approach 
between 40% to 90% respectively, depending on the populations studied and definitions 
used.7,31–33  Acute volume overload manifests in HD patients because kidney failure results in 
interdialytic weight gain (IDWG) that is secondary to excess fluid consumption.139 In patients 
with excessive IDWG, not all of the excess fluid can be removed by ultrafiltration during dialysis 
due to side-effects such as cramping and intradialytic hypotension,95,112 leading to chronic 
volume overload.52 To mitigate these effects, dialysis sessions may be shortened or skipped, 
saline treatments may be provided, or ultrafiltration rates reduced, each of which may further 
exacerbate volume overload.95,134  
 One strategy to prevent and treat volume overload and hypertension is to reduce dietary 
sodium intake, which should reduce thirst as well as subsequent fluid intake and retention.165 
Indeed, sodium restriction is a component of HD dietary guidelines to prevent adverse 
cardiovascular outcomes.66 Unfortunately, most HD patients still consume excessive dietary 
sodium and nutritional education and counseling to reduce sodium intake is largely ineffective.12 
These findings may be attributed to a high-sodium food environment and a variety of barriers to 
dietary and behavioral changes.29,77,135,136 A multitude of other HD dietary restrictions (e.g., 
phosphorus and potassium) further complicates dietary adherence.57,166  
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 Recent studies have shown that sodium can be stored in soft tissues, such as skin and 
muscle, and that elevated tissue sodium is associated with hypertension and left ventricular 
hypertrophy.19,20 Tissue sodium dysregulation, characterized by deficient lymphatic expansion, 
vasoconstriction, and excretion, is evident in aging, diabetes, and chronic kidney 
disease.19,20,55,56,82 Prior research has shown that tissue sodium levels are transiently reduced 
during dialysis,56 but no study to date has investigated if reducing dietary sodium intake reduces 
tissue sodium accumulation in HD patients. Two-recent interventions in heart failure suggest that 
providing home-delivered, commercial meals is a well-tolerated method to reduce dietary 
sodium intake,30,54 and similar meals have been formulated for the renal diet. This approach 
could also allow HD patients to meet recommendations for intake of sodium, potassium, 
phosphorous, and protein. 
The primary purpose of this study was to determine the efficacy of home-delivered, low-
sodium, dialysis-friendly (low-potassium and low-phosphorus) meals to reduce IDWG. We 
hypothesized that 4 weeks of these meals would reduce IDWG when compared to 4-weeks of a 
usual diet. In secondary analyses, we also assessed the effects of the home-delivered meals on 
dietary sodium intake, thirst, xerostomia (dry mouth), systolic and diastolic blood pressure, 
markers of chronic volume overload, and muscle sodium levels.  
Materials and Methods 
Study Population, Design, and Measurements 
Patients were recruited from a single HD clinic in central Illinois. Inclusion criteria 
included: HD treatment ≥3 days/ week; dialysis vintage ≥3 months; and age >18 years. 
Exclusion criteria included: 1) bioelectrical impedance exclusions (pacemakers and leg 
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amputations); 2) MRI exclusions (such as ferric metal implants, devices, claustrophobia, etc.); 3) 
on a sodium restricted diet approximately <1,500 mg per day; and 4) a diagnosed gastrointestinal 
disorder. The study was a sequentially designed trial of 8 weeks duration. Written informed 
consent was obtained prior to baseline testing. The study was approved by the University of 
Illinois Institutional Review Board (IRB 17530) and registered at clinicaltrials.gov 
(NCT03189758). All procedures performed were in accordance with the ethical standards of the 
1964 Helsinki Declaration and its later amendments. 
The commercial vendor PurFoods, LLC (Des Moines, IA) prepared and shipped 21 
microwaveable meals per week (equivalent of 3 meals/day) to participant’s homes during the 
intervention period (Data Supplement 1). These meals were standardized to <700 mg sodium 
each (<2,000 mg total sodium per day) and were also low in potassium and phosphorus (Data 
Supplement 2). To further prevent short-term protein energy deficits, participants were 
supplemented with 15 g Vidafuel protein (in medicine cups or mixed with water) and a kidney-
friendly snack (e.g. chips and crisps ~80 kcal and 120 mg sodium) per day during the meal 
intervention period (Data Supplement 3, https://www.vida-fuel.com). 
The overall study timeline is depicted in Figure 4.1. Patients underwent testing on a mid-
weekday dialysis day or non-dialysis day (for sodium magnetic resonance imaging) at baseline 
(0M), after 4 weeks (1M), and 8 weeks (2M), which was kept consistent at each time-point. 
Following baseline testing, patients followed their usual diet for 4 weeks (control period; CON), 
followed by 4 weeks on the low-sodium diet (intervention period; INT). The CON and INT 
periods occurred sequentially due to the potential impact of the low-sodium meal intervention on 
dietary habits or taste preferences. During CON, no additional counseling, meals, or dietary 
supplements were provided. After these 4 weeks, patients began the INT period when they 
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consumed the home-delivered meals. During INT, research staff visited the enrolled subjects at 
each dialysis session on a weekly basis to monitor, record, and positively reinforce home-
delivered meal adherence. During INT, the research staff also provided minor supplemental 
nutrition education on how to adhere to a low-sodium diet, mainly providing lists of low-sodium 
foods and snacks to supplement the provided meals (Data Supplement 4). All dietary advice and 
assessments were conducted by the research team and were approved or supervised by the clinic 
registered dietitians (RD). 
Three dietary record-assisted recalls were collected in-person at the dialysis facility, 
including 1 dialysis weekday, 1 non-dialysis weekday, and 1 non-dialysis weekend day at each 
testing time-point generally following the United States Department of Agriculture 5-pass 
method.167 Dietary recalls (24 to 48 hours) were unscheduled and conducted within the 2-week 
period prior to each testing time-point if patients were unwilling or unable to record dietary 
intake. Dietary data was analyzed using Nutrition Data System for Research (University of 
Minnesota Nutrition Coordinating Center, MN).  
Clinical data was obtained from participants treatment records one-month prior to and 
during the study period, including: IDWG, ultrafiltration (UF) rate and volume, pre-dialysis 
weight, estimated dry weight (EDW), pre-dialysis BP, monthly laboratory values, dialysate 
composition, and medications. Monthly and individual weekly IDWG and UF averages were 
calculated as the average of the 4 weeks (12 HD treatments) preceding each study time-point or 
as 3 treatments per week, respectively. Blood samples (10 mL) were obtained at each time-point 
within 5 minutes of starting HD (pre-heparin) for immediate analysis of plasma sodium, 
potassium, and phosphorus using colorimetric enzymatic assays (Renal function panel, Piccolo-
Xpress, Abaxis, Union City, CA).  
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Hydration status, a marker of volume overload, was measured using a bioimpedance 
spectroscopy device (Impedimed SFB7, Carlsbad, CA) that estimates total body water as well as 
intracellular fluid and extracellular fluid. Both absolute volume overload (volume overload = 
1.136 × extracellular fluid − 0.430 × intracellular fluid − 0.114 × body weight) and percent 
volume overload (percent volume overload = volume overload / extracellular fluid * 100) is 
calculated from bioimpedance spectroscopy parameters.168 Bioimpedance spectroscopy 
measurements were performed while seated until at least three consecutive and consistent results, 
differing less than 10%, were obtained. Standardized (e.g. sitting in a quiet room for 5 minutes) 
duplicate BP measurements were taken using an automated cuff (Mobil-O-Graph, IEM, Stolberg, 
Germany) until the two readouts differed by less than 10 mmHg and then were averaged. Thirst 
intensity and xerostomia were evaluated with a 7-item dialysis thirst inventory and an 11-item 
xerostomia inventory survey.76 The dialysis thirst inventory ranges from 7 (no thirst) to 35 (very 
thirsty) and the xerostomia inventory ranges from 11 (no dry mouth) to 55 (extremely dry 
mouth) respectively.76  
Muscle sodium concentration in the right lower leg (calf) was measured on a non-dialysis 
day using a Siemens Prisma 3T MRI scanner with two custom birdcage coils with matching 
geometry tuned to 1H- and 23Na-MRI frequencies. T1-weighted proton imaging was run with the 
following parameters: a field of view (FOV) of 280 mm2, an in-plane resolution of 256 x 256 
mm2, 16 slices at a thickness of 5 mm, repetition time (TR)=7.5 ms, echo time (TE)=3.69 ms, 5° 
flip angle, 8 averages. The T1 structural scan provided the anatomical image which allowed the 
definition of muscle region of interest. Sodium MRI was performed using the flexible twisted 
projection imaging sequence (flexTPI)169 (TR=200 ms, TE=0.5 ms, 70° flip angle, FOV=280 x 
280 x 280 mm, an effective matrix size of 44 x 44 x 44, radial fraction of 0.25, maximum 
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gradient of 4 mT/m, maximum slew rate of 150 mT/m/ms, 3 averages, total scan time of about 
15 minutes). The tissue sodium data were reconstructed on a 64 x 64 x 64 matrix using an 
iterative reconstruction approach170 implemented in MATLAB (R2019a; MathWorks, Natick, 
MA). 
Quantification of muscle sodium concentration was performed by using region of interest  
and trend analyses modified from previously published 23Na-MRI studies.19,55,56 In brief, a linear 
trend function for estimating muscle sodium level was fitted based on the concentrations and 
23Na-signal intensities of 3 calibration standards that contained sodium chloride aqueous 
solutions at 10, 30, and 50 mM. Region of interest analysis was performed in ImageJ (NIH, 
version 1.52a) by placing region of interests on calibration standards and muscles of interest, 
including medial gastrocnemius, lateral gastrocnemius, tibialis anterior, soleus, and the whole 
leg. The research personnel responsible for quantification of muscle sodium concentrations was 
blinded for subject identification. 
COVID-19 Pandemic Study Modifications 
The COVID-19 pandemic required early suspension of in-person research activities. 
Clinical data were substituted from the dialysis clinic medical records for subjects in these 
instances. For example, three sitting pre-dialysis BPs were averaged the week of each testing 
point and substituted for standardized BP, monthly laboratory values closest to each study time-
point were utilized, and dietary recalls were conducted through phone interviews with three 
subjects. There were no statistical differences in primary or secondary outcomes when these data 
points were removed from the analysis. 
Statistical Analysis  
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All monthly and weekly outcomes were assessed by repeated measures analysis of 
variance (RM-ANOVA) followed by post-hoc analysis. A p-value <0.05 was considered 
significant. Non-parametric corrections and Friedman tests were conducted when appropriate. 
The eight study weeks were then collapsed into 4 weeks split by group (CON or INT) to conduct 
additional between-subject comparisons of IDWG and UF. We then ran generalized estimating 
equations (GEE) to analyze fixed weekly and treatment effects, as well as interaction effects, for 
both IDWG and UF (SPSS GENLIN procedure). The dialysis thirst inventory and xerostomia 
inventory survey scores were analyzed with a paired t-test. All statistical analyses and figures 
were conducted or generated using a combination of SPSS version 26.0 (IBM SPSS Inc., 
Chicago, IL) and GraphPad Prism version 8.0 (GraphPad Software, San Diego, CA). 
Results 
The baseline demographic characteristics of the study population are shown in Table 4.1. 
A total of 20 subjects completed the study and the consort diagram is depicted in Figure 4.2. Six 
subjects did not complete 1M and/or 2M testing and the last three enrolled subjects did not 
undergo any in-person testing due to the COVID-19 pandemic. Error! Reference source not 
found. summarizes the dietary results and study outcomes at each time-point. Baseline dietary 
sodium intake remained constant after 4 weeks of usual diet (0M to 1M difference: 54±224 
mg/d, p=0.812). However, participants significantly reduced their sodium intake after home-
delivered low-sodium meal provision (2M), when compared to both 0M (0M to 2M difference: -
1687±297 mg/d, p<0.001) and 1M (1M to 2M difference: -1633±282mg/d, p<0.001). There were 
no changes in calories, protein, or potassium consumed at any time-point (all p>0.05, Table 4.2). 
However, there was an increase in carbohydrate consumed as well as decreases in fat and 
phosphorus consumed at 2M (all p<0.05, Error! Reference source not found.). Overall, 
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participants reported eating an average of 66±15 meals out of 84 meals provided, which 
translated to approximately 2.4±0.5 meals per day eaten for overall average adherence rate of 
79%. An average of 2.3±0.7 of those meals were consumed on weekends and an average of 
2.4±0.8 were consumed on weekdays. The four most common feedback themes provided by the 
participants were “helped with not cooking and shopping” (80%), “liked the different meal 
options and taste” (75%), “helped with thirst, fluid intake, and/or fluid gain” (40%), and “helped 
with busy work or life schedule” (30%). Common reasons given for not eating the meals 
included lack of storage, lack of appetite, and lack of preference for certain individual menu 
items. 
IDWG was significantly reduced from both 1M to 2M (-0.82±0.13 kg, p<0.001) and 0M 
to 2M (-0.59±0.14 kg, p=0.001), which was characterized by individual reductions (1M to 2M) 
in most participants (Figure 4.). IDWG and UF over the entire duration of the study is depicted 
in Figure 4.4. As expected, IDWG was higher on the long interdialytic period (3 days) on the 
weekends (2.6±1.7) compared to the shorter interdialytic period (2 days) during the week 
(2.2±1.8). RM-ANOVA revealed that the overall weekly IDWG was decreased over the course 
of the 8 week study (p<0.001), primarily driven by post-hoc pairwise differences in weekly 
IDWG when comparing the average IDWG during the 4 week control period to the average 
during the 4 intervention weeks (all p<0.05; Figure 4.4A). In addition, there were no differences 
in IDWG within the 4 control period weeks (week 1 – 4) or within the 4 intervention period 
weeks (week 5 – 8) (Figure 4.4A). The GEE analysis showed that there was a significant 
treatment effect (-0.82 ±0.14 kg; 95% confidence interval, -0.55 to -1.08 kg; p<0.001), but not 




Both overall monthly EDW (p<0.039) and pre-dialysis weight (p<0.019) were decreased 
throughout the 2 months of the study period (Error! Reference source not found.). For EDW, 
there was a significant reduction from 0M to 2M (-1.47±0.60 kg, p=0.025). For pre-dialysis 
weight, there was a significant reduction from 1M to 2M (-1.85±0.77 kg, p=0.026) and 0M to 
2M (-2.09±0.82 kg, p=0.020). Monthly UF changed in a similar pattern to that of IDWG 
(p=0.005; Error! Reference source not found.), but with a significant post-hoc reduction from 
1M to 2M (-0.48±0.10 L, p=0.001). When UF was split into the 8 weekly averages, there were 
significant overall reductions in weekly UF throughout the 8 studied weeks (p<0.05), but no 
post-hoc between-week differences (p>0.05; Figure 4.4A). According to the GEE analysis, there 
was a treatment effect (-0.43±0.13 L; 95% confidence interval, -0.17 to -0.67 L; p<0.001), but no 
time (week, p=0.703) or interaction (treatment*week, p=0.796) effects on weekly UF (Figure 
4.4C). 
Both systolic and diastolic BP remained unchanged from 0M to 1M, but were both 
reduced from 1M to 2M (SBP -18.0±3.6 mmHg, p<0.001; DBP: -5.9±2.0 mmHg, p=0.008; 
Error! Reference source not found.). One subject had an antihypertensive medication dosage 
increased from 0M to 1M (metoprolol tartrate) coinciding with a systolic BP decrease of -10 
mmHg from 0M to 1M. Another subject had carvedilol dosage decreased and lisinopril and 
clonidine discontinued from 1M to 2M, coinciding with a systolic BP increase of 3 mmHg from 
1M to 2M. There were no changes in dialysate composition, including dialysate sodium 
concentration (136.8±1.6 mEq/L), at any study time-point (data not shown).  
In the subset of patients (N=11) with complete bioimpedance data, participants had 
significant reductions in total body water and extracellular fluid at 2M (p<0.05, Error! 
Reference source not found.) but no changes in intracellular fluid (p=0.148, Error! Reference 
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source not found.). There were significant reductions in both absolute and percent volume 
overload at 2M (both p<0.05, Error! Reference source not found.), driven by 0M to 2M 
reductions (-1.08±0.33 L, p=0.008 and -5.5±1.8 %, p=0.010 respectively). In the subset of 
patients (N=7) with muscle sodium analyzed, there were no significant changes in muscle tissue 
sodium or plasma sodium at any time-point (all p>0.05, Error! Reference source not found.). 
Participants had reductions in plasma phosphorus (1M to 2M: -1.55±0.21 mg/dL, p=0.005 and 
0M to 2M: -1.00±0.32 mg/dL, p<0.001) but not in plasma potassium at 2M (overall p=0.160, 
Error! Reference source not found.). Participants significantly reduced both self-reported thirst 
score (-4.4±1.3 p=0.003) and xerostomia score (-6.7±1.9 p=0.002).  
Discussion 
The primary finding in this study was that 4 weeks of home-delivered, low sodium meals 
reduced IDWG when compared to the usual dietary habits of patients on HD. Other 
improvements included reductions in dietary sodium, thirst and xerostomia scores, SBP and 
DBP, volume overload, and plasma phosphorus; however, tissue sodium did not change after the 
4-week low-sodium meal intervention. The provided meals significantly reduced both sodium 
and phosphorus intake without reducing total calorie and protein intake. Another key finding was 
that participants had modest reductions in dialysis UF volumes during the meal provision period, 
indicating that not only were patients less hypervolemic, but they required less aggressive 
treatments to achieve this. Taken together, this data indicates that home-delivered meals may be 
a safe and effective way of improving the nutritional status and cardiovascular health in HD 
patients. 
The average baseline sodium intake of our participants (> 2,300 mg per day, Table 4.2) 
was similar to or slightly lower than the amounts reported in other observational or interventional 
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studies in HD patients.25–27,130–133,171 Compared to a low sodium intervention by Rigby et al.171, 
the magnitude of the reduction in sodium intake in our study was smaller, yet the reduction in 
IDWG was comparable. By contrast, our study had a greater reduction in sodium intake than 
reported by Maduell et al.133, with a similar or greater reduction in IDWG. These studies were 
similar in sample size to ours, but our intervention period (4 weeks) was longer than some (1 - 2 
weeks),133,171 yet shorter than others (16 weeks – 48 months).25–27 However, these studies with 
longer intervention periods have not demonstrated successful reductions in both sodium 
consumption and IDWG.12  
 In a recent pilot study,129 we aimed to reduce chronic volume overload in HD patients 
through a comprehensive approach modeled after the successful volume control protocol 
implemented in Izmir, Turkey.7,47,165,172 After 6 months, we achieved modest reductions in 
markers of volume overload, despite no detected change in dietary sodium intake.129 Cultural 
differences in adherence likely contributed to the lower adherence and more modest results 
compared to the Izmir group, as high-sodium foods are present in both countries.173 Furthermore, 
there are numerous barriers to low-sodium dietary adherence in the U.S. that have previously 
been reported.29,77,135,136 The home-delivered meal approach used in the current study may be a 
more efficacious approach for reducing sodium intake, especially in patients with higher 
IDWG’s, because it bypasses many of the barriers with following a low-sodium diet or other 
renal diet restrictions. However, cost considerations should be taken into account for provision of 
these meals ($6.99 per renal meal; $587 per patient in this study).  
 Although there were no significant differences in tissue sodium levels at any time-point, 
there was a numerical increase during the observational period and a numerical decrease during 
the intervention period of approximately 4% – 8%. Our sample size was unfortunately limited by 
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the exclusionary criteria for conducting MRI measurements in HD patients and interruptions in 
our research due to the 2020 COVID-19 pandemic. Our study was not powered (observed 1-
β>0.1) to detect muscle sodium changes, as this was an exploratory outcome. Based on a post-
hoc power analysis, we would require a sample size of at least 76 subjects to detect a significant 
within-subject change in muscle sodium, given our observed effect size (Cohen’s d) of 0.327. A 
hypothesis that may explain this modest effect of the meals on tissue sodium is that tissue 
sodium is not hypertonic, so it may be more reflective of extracellular volume expansion, and 
thus insensitive to change in much the same way as blood sodium concentrations.174 However, 
this hypothesis requires further investigation and future studies should investigate if longer term 
reductions in dietary sodium intake yield more robust changes in muscle sodium.  
There are several limitations to our study. First, this pilot trial was conducted as an 
unblinded, repeated measures, sequential design, as opposed to a randomized control trial or 
cross-over design. Second, we had relatively short-term study intervention period (~1 month) 
and a small sample size. Moreover, only about one-third of approached patients were willing to 
participate in our study, despite receiving free, home-delivered meals for one month.  However, 
this was similar to the eligibility rate (30%) and final enrollment rate in a similar study by Sevick 
et al.26 A similar intervention in heart failure patients demonstrated a 42% consent rate among 
eligible and approached individuals.54 These modest recruitment rates may be reflective of a 
general resistance that many dialysis patients have towards participate in research. Future studies 
should include subjective analyses to determine if patients have concerns about the home-
delivered meals or if they refused to participate for other reasons. Third, it the self-reported 
dietary intake and meal adherence may have differed from reported intake due to meal fatigue or 
other factors. Fourth, we also lacked patient-reported outcomes and were not able to report total 
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fluid consumption during the meal intervention period due to the omission of water content in 
the customized intervention meals. Fifth, we did not control or standardize any dialysis 
prescription parameters in this study. Despite this, these parameters remained mostly unchanged 
during our intervention period.  
Conclusion 
In summary, home delivery of low-sodium, kidney friendly meals is a feasible short-term 
approach to reduce sodium intake, thirst, xerostomia, IDWG, BP, plasma phosphorus, and 
volume overload in HD patients. Future studies should be conducted with larger sample sizes 
over longer durations to determine if these benefits persist and can translate to reduced 
hospitalizations, reduced mortality, and improved patient quality of life, and to determine if the 
approach is cost-effective. 
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Table 4.1 Subject Demographics 
Variable Value 
n 20 
Age (SD), yr 55 (12) 
BMI (SD), kg/m2 40.7 (16.6) 
Women, n (%) 9 (45%) 
Black/African American, n (%) 13 (65%) 
Diabetes, n (%) 14 (70%) 
Cardiovascular disease, n (%) 10 (50%) 
MWF day dialysis, n (%) 7 (35%) 
1st/2nd/3rd shift dialysis, n 7/11/2 
BP medications, mean 2.9 (1.7) 
Dialysis vintage, years 4.5 (3.2) 
All values reported as mean (SD) unless otherwise indicated. BMI, body mass index; MWF, 




Table 4.2 Changes in Study Outcomes 
Variable  Time-point   
 0M 1M 2M P-value 
Clinical data     
Interdialytic weight gain, kg* 2.9±1.2 3.1±1.1 2.3±1.1 <0.001 
Ultrafiltration, L† 2.9±1.1 3.1±1.1 2.6±1.0 0.005 
Pre-dialysis weight, kg* 115.8±41.2 115.6±41.1 113.7±40.3 0.019 
Estimated dry weight, kg‡ 112.4±40.0 112.6±40.1 111.2±40.0 0.039 
Systolic BP, mmHg* 161±18 161±24 143±18 <0.001 
Diastolic BP, mmHg* 91±13 88±11 82±14 0.001 
Dietary data     
Calories 1844±620 1957±706 1914±181 0.662 
Calories/kg 17.4±6.7 18.8±8.9 19.0±7.1 0.282 
Protein, g 72±18 75±19 69±10 0.350 
Protein/g/kg 0.67±0.22 0.73±0.31 0.68±0.26 0.331 
Carbs, g* 221±98 230±99 295±44 <0.001 
Fat, g* 76±30 83±34 53±10 <0.001 
Sodium, mg* 3506±1303 3560±1310 1873±345 <0.001 
Sodium, mg/calories* 1.94±0.56 1.86±0.42 0.97±0.11 <0.001 
Potassium, mg 1957±553 2053±582 2013±235 0.731 
Phosphorus, mg* 1022±278 1083±261 760±99 <0.001 
Volume parameters (n=11)     
Total body water, L† 56.5±15.3 58.3±13.5 54.3±11.8 0.040 
Extracellular fluid, L* 25.2±6.1 25.6±6.2 23.8±5.4* 0.007 
Intracellular fluid, L 31.3±9.5 32.7±7.8 30.6±7.0 0.148 
Volume overload, L‡ 2.9±4.9 2.9±5.1 1.9±4.6 0.041 
Volume overload, %‡ 14.2±21.3 11.0±21.6 8.6±21.0 0.036 
Tissue sodium (n=7)     
Lateral gastrocnemius Na, mM 22.6±4.4 23.3±4.3 21.5±5.8 0.609 
Medial gastrocnemius Na, mM 25.7±5.8 26.2±7.0 24.7±10.3 0.870 
Tibialis anterior Na, mM 22.9±4.8 22.7±3.9 21.5±7.3 0.793 
Soleus Na, mM 21.5±4.0 22.1±4.7 21.0±5.9 0.794 
Whole leg Na, mM 21.3±3.3 21.9±4.1 20.7±5.9 0.699 
Laboratory values     
Serum Na, mmol/L 141.0±3.8 139.8±3.4 140.1±2.8 0.302 
Serum Phosphorus, mg/dL* 6.3±1.4 6.9±1.3 5.3±1.3 <0.001 
Serum Potassium, mmol/L 4.9±0.9 5.0±0.6 4.7±0.5 0.160 
Thirst and Xerostomia     
Dialysis thirst index, total score - 19.2±6.5 14.7±5.4 0.003 
Xerostomia index, total score - 27.3±10.9 20.6±9.2 0.002 
All values are reported as mean±SD. BP, blood pressure; Na, sodium. 
* 2M different from 0M and 1M (p-value<0.05),  
† 2M different from 1M only (p-value<0.05), 
‡ 2M different from 0M only (p-value<0.05).  
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Figure 4.1 Study Timeline 
 
Figure 4.1: The study trial was sequential in design. After participant screening and baseline 
testing (0M), subjects underwent 4 weeks of usual (observational) diet. Participants then 
underwent 4-week testing (1M) followed by 4 weeks of low-sodium (intervention) diet and 





Figure 4.2 Study Consort Diagram 
 
Figure 4.2: Participants were recruited and enrolled between August 2019 and May 2020. The 
most common reasons for declining to participate were “not interested” and “prefer to eat own 
food”. Our original enrollment target was a convenience sample of n=32 to exceed a sample size 
determination (n=14) based on matching the small effect-size of an internal pilot study129 
(α=0.05, β=0.20, E=0.30, SΔ=0.40). For comparison, a previous similar study171 was powered 
(n=24, α=0.05, β=0.20, SΔ=1.0) to detect a 0.81 kilogram difference (Δ) in IDWG. IDWG, 




















Figure 4.3 Individual Changes in Monthly IDWG 
 
Figure 4.3: IDWG changes in the CON month were inconsistent and not significant. By 
contrast, most participants had IDWG reductions in the INT period compared to CON. IDWG, 








Figure 4.4 Weekly IDWG and UF Volume by Time and Treatment 
 
  
Figure 4.4: A) Changes in IDWG and UF during the 8-week study period, assessed by separate 
RM-ANOVA, superimposed on the same graph to highlight similar temporal changes in these 
variables. For IDWG, there were significant reductions from within CON to INT. For weekly 
UF, there was an overall reduction over time, but no significant post-hoc reductions observed. B) 
IDWG split and superimposed by CON and INT. C) UF split and superimposed by CON and 
INT. IDWG, interdialytic weight gain; UF, ultrafiltration; RM-ANOVA, repeated measures 
analysis of variance; GEE, generalized estimating equation; CON, control period; INT, 
intervention period. * post-hoc p-value<0.05 for IDWG only. 
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CHAPTER 5: DIETARY PATTERNS, BEHAVIORS, AND BARRIERS OF PATIENTS 
ON HEMODIALYSIS  
 
Abstract 
Introduction: Dietary sodium restriction is recommended to help manage thirst and fluid intake 
to reduce chronic volume overload in hemodialysis (HD) patients. However, compliance with 
this recommendation is poor, and the barriers responsible for this have not been thoroughly 
examined in combination with dietary patterns and knowledge. The purpose of this study was to 
evaluate the relationship between usual dietary patterns, nutritional knowledge, and behavioral 
barriers in HD patients. 
Methods: We recruited 20 subjects (55+12 years, BMI 40.7+16.6 kg/m^2, 45% male, 65% AA, 
70% DM, 50% CVD) from a HD clinic in central IL. We assessed clinical records and normal 
dietary intake through an analysis of dietary records collected on 6 days (2 HD, 2 non-HD, and 2 
weekend days) over one month. We also collected one sodium knowledge and five behavioral 
questionnaires to determine levels of low-sodium education and barriers to following a low-
sodium diet. 
Results: Participants frequently consumed high-sodium, ultra-processed and processed foods and 
ate many meals away from the home. The largest contributors to dietary sodium intake also 
contributed to elevated phosphorus and potassium in the diet. Despite several deficits, subjects 
scored high on most assessed educational areas. A common behavioral challenge was the 
hemodialysis diet and fluid restrictions; however, participants were generally confident in 
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limiting saltshaker usage and salt intake overall. Normative behavioral beliefs were most closely 
associated with dietary sodium intake and fluid intake.  
Conclusions: We identified several areas for improving nutritional education deficits and dietary 
behaviors. Dietary patterns also suggested additional areas of sodium knowledge assessment that 
are needed. The nutritional patterns observed in this study suggest that the dietary 
recommendations for HD patients should focus primarily on reducing processed food 
consumption for better adherence to a low-sodium diet, which may also translate to reduced 
phosphorus and potassium intake. The behavioral instruments in this study should be condensed 
and evaluated as feedback tools to guide counseling interventions and improve dietary patterns, 







It is well established that the dietary recommendations for hemodialysis (HD) patients are 
complex and hard to follow.57,166 Routine maintenance HD therapy is burdensome and requires 
patients to navigate many medical and socioeconomic challenges in addition to their dietary 
challenges. Patients attend thrice weekly HD sessions and suffer treatment-related symptoms, but 
also have to manage a number of medications, including antihypertensive medications, 
phosphate and potassium binders, and iron and calcium supplements.6,91,93 Prevalent 
socioeconomic factors in HD that complicate dietary adherence include many social 
determinants of health such as mobility, food security, nutrition and health literacy.175 The HD 
diet has been dubbed “the art of restrictions”, due to its focus on restricting fluid intake for 
reducing interdialytic weight gain (IDWG), as well as the consumption of foods high in 
potassium, phosphorus, and sodium.57,166 This includes restrictions on many high phosphorus and 
potassium foods that are typically considered “healthy”, such as nuts, legumes, whole grains, 
fruits, vegetables and dairy.57,166 Additional dietary recommendations related to other prevalent 
comorbidities such as diabetes and/or cardiovascular disease further complicate the medical 
nutrition therapy for these patients.166 Increasing evidence has also demonstrated a lack of 
efficacy for the standard HD diet and fluid restrictions.166 These many barriers contribute to the 
often-reported difficulties, frustrations, and lack of adherence in following the HD diet.77,160  
Due to the complexity of the renal diet and its apparent lack of efficacy, many are now 
calling for a liberalized approach to the renal diet restrictions.57,166,176,177 One proposed strategy is 
to primarily shift the focus of the renal diet to restrict the intake of processed foods, as these tend 
to be high in sodium, as well as phosphorus and potassium additives.57,178–182 Another example is 
following a less than 1:1 sodium-to-calorie ratio (e.g. eating less than 2,000 mg sodium on a 
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2,000 calorie diet.57 Thus, reducing high-sodium processed food consumption could also 
improve hyperphosphatemia and hyperkalemia in HD. Reduction of dietary sodium intake 
should reduce IDWG, volume overload, cardiovascular morbidity and mortality.24,40 
Unfortunately, sodium restriction has not been at the forefront of clinical practice.68 Moreover, 
research studies examining the efficacy of reducing dietary sodium intake in HD patients are 
rare, and mostly indicate that these strategies have been unsuccessful.8,12,52  
 Routine clinical counseling and research interventions have focused on nutritional 
education as the tool to reduce dietary sodium intake,12,183 which does not always impact beliefs 
or lead to behavior change.184,185 Furthermore, most of the dietary education in HD has focused 
on restricting potassium and phosphorus, and there is a lack of validated and reliable 
questionnaires for assessing sodium knowledge in dialysis patients.160 Some nutritional 
interventions have shifted to behavioral strategies to improve low-sodium adherence, but these 
have been largely unsuccessful as well.12 Both cross-sectional analyses and interventions report 
numerous barriers towards following low-sodium diets in HD, such as lack of self-efficacy, time, 
cost, and convenience.29,77,135,136,186,187 However, few interventional studies directly target these 
barriers. Because barriers likely vary among different patients, it is important to incorporate the 
barriers assessed by behavioral instruments as feedback to guide counseling strategies. Studies in 
dialysis have largely failed to report reductions in behavioral barriers with education and 
counseling. There also is little research examining the association of educational knowledge with 
dietary patterns, or triangulating this information with low-sodium beliefs, barriers, and 
behaviors. The purpose of this study was to compare and contrast the usual dietary patterns of 




This study was a secondary analysis of a study where we recruited 20 patients (45% male 
and age > 18 years) undergoing thrice weekly maintenance HD, for at least 3 months, from a 
clinic in Central Illinois. Exclusion criteria in the original study included: pacemakers, major 
limb amputations, exclusions for 3T magnetic resonance imaging, currently following sodium 
restricted diet <1,500 mg per day, active gastrointestinal disorders, and active infections. 
Intervention Protocol 
Enrolled participants followed a usual diet for 4-weeks followed by 4-weeks of home 
delivered renal meals. Subjects underwent baseline testing at three time-points starting with 
baseline testing before their usual observational diet (0M), before receiving low-sodium home-
delivered meals (1M), and after receiving the meals (2M). In the first 4 study weeks, patients 
were encouraged to maintain their current usual dietary regimen in terms of total caloric intake, 
macronutrient composition, and food patterns: no additional counseling, meals, or dietary 
supplements were provided. In the second 4 study weeks (weeks 5 to 8), participants began 
consuming the low-sodium diet that included three commercially prepared meals delivered 
directly to the patients’ home each week. Mom’s Meals (https://www.momsmeals.com) provided 
and standardized meals to <700mg sodium each to meet the National Kidney Foundations (NKF) 
recommendations of low potassium and phosphorus for kidney disease. To further prevent short-
term protein energy deficits, participants were supplemented with 15 g Vidafuel 
(https://www.vida-fuel.com) protein per day and snacks during the meal intervention period. 
Data in this analysis is primarily reported on the collapsed 0M and 1M time-points. 
Dietary Intake and Patterns 
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Three dietary record-assisted recalls were collected at each major study time-point, 
generally following the United States Department of Agriculture automated pass method.167 
Dietary recalls were unscheduled and conducted within the 2-week period prior to each testing 
time-point if patients were unwilling or unable to record dietary intake. Each dietary recall for 
each participant was collected in-person at the dialysis facility for a total of 1 dialysis weekday, 1 
non-dialysis weekday, and 1 non-dialysis weekend day at each time-point. Thus, the maximum 
timeframe for the recalls typically ranged from 24 to 48 hours. Nutrient analysis focused on 
major macronutrients and major micronutrients, as well as food groups. Dietary data were 
analyzed using NDSR (University of Minnesota Nutrition Coordinating Center, MN). For 
purposes of this study analysis, the 0M and 1M dietary time-points were collapsed to better 
represent 6 days of usual dietary patterns (i.e. 2 dialysis days, 2 non-dialysis days, and 2 non-
dialysis weekend days). Food groups were derived from Ultra-processed and processed food 
definitions were categorized according to the NOVA diet classification system.188 To compare 
the agreement between weekly fluid intake from dietary records with actual weekly IDWG from 
clinical records over the course of a month, we calculated estimated IDWG based on the 
following calculation: Estimated IDWG (kg) = Fluid intake (g) / 1000 g/kg * 2.3 (7 days in a 
week divided by 3 treatments per week). 
Sodium Attitudes 
All questionnaires were administrated only once, over the course of a week at baseline, to 
reduce survey fatigue. Attitudes to a low-sodium diet were obtained from a previously published 
Dietary Sodium Restriction Questionnaire (DSRQ) in heart failure (27 items), that was modified 
to use in HD with permission from Dr. Debra Moser (University of Kentucky, Lexington, 
KY).185,189 The DSRQ asks specific measurement of patients' perceptions of their barriers to, and 
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attitudes toward, following a low-sodium diet. The original valid and reliable DSRQ is based on 
the Theory of Planned Behavior (TPB) to predict low-sodium dietary adherence and has three 
subscale constructs: attitude (AT, 6 items), subjective norms (SN, 3 items), and perceived 
behavioral control (PBC, 7 items). Modifications to the DSRQ included expanding the total 
question content to 47 items, with 11 items as descriptive questions and 12 items in each of three 
major constructs. These modifications were advised by survey statisticians and through pilot 
testing with a small sample of HD patients (n=12). The expanded and revised DSRQ went 
through validity testing (content validity ratio) by an expert panel of 5 renal nutrition 
practitioners/researchers as part of its implementation in this study. Content validity index/ratio 
was calculated for all questions of the DSRQ relating to the topics of appropriateness, 
importance, and phrasing. 
Sodium Knowledge 
The original Short Sodium Knowledge Survey (SSKS)160 consists of six questions 
evaluating whether the participant can select items with the greatest sodium (1 item), strategies 
to decrease sodium (2 items), the recommended sodium intake (1 item), and whether they have 
ever been instructed to decrease their sodium intake (2 items). The SKSS was developed with 
content input from five expert individuals in the renal and cardiovascular field.160,190 This survey 
was conducted in 155 patients with CKD and was derived from a larger questionnaire (Kidney 
Knowledge Survey) and study assessing patient knowledge about CKD.190 Validation and 
reliability results for this survey have not been reported or published. In a previous study,129 we 
expanded this questionnaire to 30 total items (28 scored) based on experience with local patient 
populations in central Illinois on HD. The modified sodium knowledge questionnaire (SKQ) was 
updated for readability and implementation to include pictures, food labels, and large text. Added 
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questions included topics related to understanding the sodium-to-calorie ratio, selecting meal 
components with high-sodium, selecting low-sodium foods at the grocery store, cooking, and 
eating out.  
Sodium Barriers 
These questionnaires include 1) 26-item renal adherence attitudes for dietary 
recommendations (RAAQ),186 2) 25-item renal adherence behaviors for dietary 
recommendations (RABQ),186 3) sodium self-efficacy in HD (SEHD),77,187 and 4) problems with 
the HD diet (PHDD).77 Both the RAAQ and RABQ were validated with independent measures 
of kidney disease biomarkers in 35 HD patients.186 The RAAQ investigates four factors related 
to attitudes to social restrictions (8 items), well-being (11 items), self-care/support (4 items), and 
acceptance (11 items). The RABQ investigates five factors related to adherence to fluid 
restrictions (11 items), adherence regarding potassium and phosphate restrictions (5 items), 
adherence regarding self-care (2 items), adherence regarding sodium intake (2 items), and 
adherence in times of particular difficulty (5 items). Reliability of the RAAQ and RABQ resulted 
in Cronbach’s alpha values of greater than 0.70 for all factors except for self-care/support and 
adherence regarding potassium and phosphate restrictions.186 Original reported test-rest 
reliability of the RAAQ and RABQ resulted in significant (p<0.10) Pearson correlations greater 
than 0.71 for all factors except for self-care/support and adherence regarding potassium and 
phosphate restrictions.186 Permission was granted by Dr. Hannah McGee (Royal College of 
Surgeons, Ireland) for use and future modification of the RAAQ and RABQ. 
The SEHD questionnaire was validated (construct and convergent) in 124 HD patients 
and underwent reliability testing.187 The SEHD demonstrated an overall Cronbach’s alpha of 
0.93 and three factors (sources of dietary sodium, daily schedule to restriction sodium, and 
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context factors about dietary sodium) accounted for 67.8% of variance in the factors 
measured.187 Test-retest reliability and discriminant validity has not been conducted for this 
survey. The PHDD questionnaire was developed in 122 HD patients and was adapted from the 
“The Barriers to Healthy Eating Scale”.77 The PHDD evaluates subscales related to dietary 
problems related to the participant's physical condition, resource adequacy, social network, 
behavioral factors, and technical difficulties related to a renal diet. Validity and reliability for the 
PHDD has not been reported or published. Permission was granted by Dr. Mary Ann Sevick 
(NYU Lagone Health, NY) for use and future modification of the SEHD and PHDD. 
Statistical Analysis  
All quanitative outcomes were assessed by descriptive statistics (mean, standard 
deviation, minimum, maximum, confidence intervals). Both absolute content and the sodium-to-
calorie ratio (sodium in mg divided by calories), a marker of a high-sodium consumption diet57, 
were analyzed by NSDR food categories. Cronbach’s alpha and standardized (1-5 scale) grand 
means were calculated for all survey instruments and subscales of the DSRQ. The content 
validity index/ratio was calculated for all questions of the DSRQ relating to the topics of 
appropriateness, importance, and phrasing. Pearson correlation coefficients were calculated to 
evaluate the relationship between survey instruments. Simple linear regression models were run 
with dietary sodium intake as the dependent variable and the grand mean of each survey 
instrument and subscale of the DSRQ in separate models to avoid multicollinearity. Paired 
samples t-test and Bland-Altman regression analysis was conducted to determine the agreement 
between estimated and actual IDWG. For all objectives, data normality (Shapiro-Wilk, p<0.01) 
and homogeneity of variance (Brown-Forsythe p<0.01) was verified to fulfill parametric 
assumptions. A p-value <0.05 was accepted as significant for all statistical analyses. All 
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statistical analyses and figures were conducted or generated using a combination of SPSS 
version 26.0 (IBM SPSS Inc., Chicago, IL) and GraphPad Prism version 8.0 (GraphPad 
Software, San Diego, CA). 
Results 
A total of twenty HD patients completed the study and were included in the analysis. 
Participant demographics and dietary intake are shown in Table 5.1. Participants did not 
participate in any co-interventions during the study period and did not participate within any 
dietary interventions within 3 years prior to study enrollment. Approximately 85% of 
participants had hyperphosphatemia (phosphorus ≥5.5mg/dl) and 15% of participants had 
hyperkalemia (potassium >5.5mg/dl). Participants were prescribed an average of 1.2 ± 0.5 
classes of phosphate binders (prescribed to 95% of participants). Mean prescribed 
antihypertensive medications were 2.9 ± 1.7 classes per day (prescribed to 90% of participants).  
Dietary Intake and Patterns 
Participants (95%; n=19) were generally above recommendations for dietary sodium 
intake in HD (2.0 g or 85 mmol of sodium).66 This was despite the majority of participants (93% 
of respondents) reporting following a low-sodium diet (“Yes” as opposed to “No) at least “half 
of the time” and intending to follow a low-sodium diet at least “a moderate amount”Error! 
Reference source not found.. Fluid estimated IDWG was not significantly different from 
measured IDWG (-0.09 ± 1.29 kg, p = 0.749) during the 4-week usual dietary period; regression 
of the mean difference between the actual and estimated IDWG on the mean of both of these 
IDWG measures was also not significant (b=0.10, t=0.665, p=0.515, Figure 5.1). Refined grains 
and sugar sweetened beverages were the most frequent food categories eaten in terms of servings 
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per day (Supplementary Table 1.). The top categories of foods contributing to cumulative 
proportional sodium intake (mg) are listed in Table 5., consisting primarily of ultra-processed 
foods. Dietary sodium intake was a significant predictor of both estimated IDWG and actual 
IDWG (Table 5.3), which are plotted in Figure 5.2. 
Survey Summary Statistics 
All five of the collected surveys had a good Cronbach’s alpha > 0.85 (SEHD=0.93, 
PHDD=0.85, RAAQ=0.91, RABQ=0.89, DSRQ=0.88).191 The mean survey scores were 3.92 ± 
1.04 (SEHD), 3.54 ± 0.82 (PHDD), 3.54 ± 0.60 (RAAQ), 3.57 ± 0.51 (RABQ), and 3.74 ± 0.41 
(DSRQ). The modified DSRQ had a content validity index/ratio of >0.80 for all questions 
relating to the topics of appropriateness, importance, and phrasing. Each DSRQ subscale had a 
Cronbach’s alpha > 0.88 (AT=0.88, SN=0.92, PBC=0.88). Correlation analysis resulted in 
generally moderate-strong positive associations (r > 0.60, p<0.05) among all the five survey 
instruments, except for comparing the DSRQ to the SEHD (r=0.21, p>0.05) and PHDD (r=0.35, 
p>0.05). The mean scores for the DSRQ constructs were 4.06 ± 0.59 (AT), 3.79 ± 0.63 (SN), and 
3.36 ± 0.41 (PBC).  
Sodium Knowledge  
Participants generally scored above 70% across all sodium knowledge questions and 
major concepts. However, there were several most commonly missed sodium knowledge 
questions relating to the most frequent foods and highest sodium foods eaten (Supplementary 
Table 2.), which included refined grains, canned vegetables, and processed meats and foods. 
Processed foods were the largest contributors to both absolute sodium intake and the sodium: 
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calorie ratio, despite few participants incorrectly missing these questions (Supplementary Table 
2.). 
Sodium Attitudes, Beliefs, and Barriers 
 Participants had the least self-efficacy for following the fluid restrictions and following 
the general HD diet, but the most self-efficacy for avoiding saltshaker usage (Supplementary 
Table 3.). The largest problems following the HD diet were the general dietary restrictions, 
while the least reported problems were meal autonomy, grocery store distance, time to cook, and 
social support systems (Supplementary Table 4.). The most negative behavioral attitudes were 
related to perceived behavioral control, such as taste, while the most positive attitudes were 
related to the benefits of following a low-sodium diet and of relating to dialysis staff 
(Supplementary Table 5.). For adherence attitudes, the most negative attitudes were related to 
following HD and fluid restrictions, while the most positive were the recognition of importance 
of fluid and salt restrictions (Supplementary Table 6.). Food cravings and fluid restrictions 
were the most negative adherence behavior, while the most positive behaviors were restricting 
alcohol intake, salt/saltshaker, and taking medications appropriately (Supplementary Table 7.).  
When summarizing the behavioral challenges across all instruments, common themes for 
the most problematic concerns were noted for fluid restrictions, following HD dietary 
restrictions, high-sodium foods, and meal autonomy (Supplementary Table 8). There was little 
overlap among instruments for the least problematic concerns, except self-reported limiting 
saltshaker usage, limiting salt/sodium intake, social support, and the benefits of following a low-
sodium diet. (Supplementary Table 8Error! Reference source not found.). When comparing 
dietary patterns among sodium knowledge deficits and behavioral barriers, there were conceptual 
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overlaps among processed food consumption and consumption of foods outside the home (Table 
5.4). 
Simple linear regression revealed that only the DSRQ instrument was a significant 
predictor of dietary sodium intake (Table 5.3). When evaluating the DSRQ subscales, this 
appeared to be driven by the subjective norm construct, but not attitudes and perceived 
behavioral control, significantly predicting dietary sodium intake (Table 5.3). SEHD was a 
significant predictor of fluid estimated IDWG (i.e. fluid intake) and there was a trend for 
prediction by the DSRQ subjective norm construct (Table 5.3).  
Discussion 
The primary finding in this study is that participants frequently ate processed foods and 
foods outside the home, scored highly on measures of sodium knowledge, and had barriers 
relating primarily to general HD diet and fluid restrictions. A high intake of processed food and 
frequent eating out contributed to high levels of dietary sodium, phosphorus and potassium. 
While participants generally had adequate sodium knowledge on most assessed areas, there were 
educational deficits related to refined grains, processed foods, and the sodium: calorie ratio. 
Although our intent was to focus more on sodium-related attitudes and behaviors, the most 
common reoccurring concerns and themes among patients were related to HD diet and fluid 
restrictions across several instruments. We identified many individual and most common low-
sodium behavioral areas of concerns that potentially contributed to the dietary patterns observed. 
However, these were not necessarily statistically associated with dietary sodium intake. Common 
themes that were identified by most participants included: 1) confidence in avoiding salt intake 
overall; 2) confidence in avoiding saltshaker usage; and 3) high self-reported low-sodium 
adherence. These themes were evident despite nearly all participants exceeding 
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recommendations for dietary sodium intake. This finding was concerning and revealed a 
disconnect between the low-sodium diet patients believed they were following and the excessive 
sodium consumption their diets revealed. Overall, these findings suggest while knowledge was 
mostly adequate, educational deficits may still be contributing to observed attitudes and 
behavioral beliefs that lead to high sodium consumption.  
 Few studies have focused on primarily low-sodium education and behavioral counseling 
to improve IDWG, volume overload, and other subsequent clinical outcomes. Several recent 
studies proposed and explored dietary sodium restriction as a core component of volume control 
in HD patients.7,13 Unfortunately, they have largely been unsuccessful in reducing dietary sodium 
intake likely due the complexity of knowledge, behavioral attitudes, and changes need to follow 
a low-sodium diet.12 Clark-Cutaia et al.77 reported that younger individuals reported more 
problems and lower self-efficacy following the HD diet. St. Jules et al.29 identified eight of the 
most prevalent barriers to reducing sodium intake in HD patients, and found that tiredness to 
cook and poor appetite were somewhat associated with dietary sodium intake. Hu et al.136 found 
a trend for lower self-efficacy being associated with reduced low-sodium dietary adherence and 
vice-versa. Study participants were also most confident in avoiding table salt while least 
confident in limiting processed meats and salty snacks. A study of semi-structured interviews by 
Clark-Cutaia et al.135 reported that time, convenience, and finances reduced adherence to HD 
recommendations. Notably, participants in the interview positively rated the impact of routine 
dietary counseling, but that more individualized efforts are needed. It is important to note much 
of this data originate from a single research group and large-scale intervention.26,29,77,135,136 
Though other studies have generally reported similar findings.192–195  
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Several of our research findings are consistent and expand on the previous literature on 
adherence to dietary recommendations in HD. Firstly, we confirm the well-established difficultly 
for most patients to adhere to the HD and fluid restrictions. Our patients also had high 
confidence in limiting shaker use and salt intake overall, indicating that this is a common 
message in HD centers, even though sodium consumption remains high. Additionally, it is 
evident that efforts to follow a low-sodium diet should focus on restricting the consumption of 
processed foods that are high in sodium, and increasing the consumption of whole foods that are 
naturally low in sodium, as well as potassium and phosphorus additives.57,166  
Our findings that HD patients had low sodium self-efficacy are similar to previous 
literature, but they were not associated with sodium intake. Instead, across all instruments and 
constructs evaluated, we found that normative or social beliefs (DSRQ SN construct) were most 
highly associated with actual sodium intake. For example, a single unit increase in the unipolar 
Likert-scale in overall normative beliefs predicted a reduction in dietary sodium intake of -1.4 
g/sodium/day and explained 43% of the variance in sodium consumption. This revealed a strong 
association between the expectation of patients and how closely a patient follows a low-sodium 
diet (i.e. motivation to comply with the beliefs of significant others).185 In this construct category 
are topics relating to: 1) whether patients believe other individuals think they should follow a 
low-sodium diet; and 2) whether these patients care to follow this advice from other individuals 
such as nephrologists, dietitians, staff, family members, and peers. Notably, HD facilities in 
Izmir, Turkey have long established what has been described as a “culture of dietary sodium 
restriction” where clinic MD’s, RN’s and technicians emphasize the importance of reducing 
sodium intake.129,165 In patients with heart failure, SN beliefs was one factor most closely 
associated with sodium intake.184 However in the HD literature to date, survey instruments have 
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yet to capture a measure of the culture relating to sodium restriction in dialysis facilities. 
Therefore, the DSRQ subjective norm construct could be implemented as a qualitative tool to 
assess the dialysis facility culture relating to low-sodium diets among providers, patients, and 
their social support groups.  
 Survey instruments have proposed many different attitudes and behaviors to following a 
low-sodium diet in HD, but few have determined the association of these barriers with diet or 
demonstrated how these barriers can be reduced with education and counseling. One study196 has 
suggested that taste is the most important factor related to low-sodium dietary adherence. Indeed, 
taste was one of the three most important attitudes reported by the patients on the DSRQ. This 
might mean that counseling efforts to reduce other dietary adherence behaviors could be less 
effective than assisting patients to eat tasteful but low-sodium foods. We recently conducted a 6-
month nutritional education and counseling pilot study to reduce dietary sodium intake and VO 
in patients on HD.129 The nutritional component of this study focused primarily on the three 
concepts of: 1) cooking better (with lower sodium food), 2) shopping better (for low sodium 
foods), and 3) eating out less often (to avoid high sodium foods from restaurants). Unfortunately, 
subjects did not significantly reduce their dietary sodium intake in this study.129 One limitation of 
this previous pilot study was that we did not assess behavioral barriers thoroughly as in this 
current observational study and incorporate them into the nutritional intervention.  
Successful reduction of sodium intake may translate to reduced processed food intake, 
which could improve diet quality and reduce phosphate and potassium additive consumption as 
well. Nonetheless, there were several low-sodium educational topics that were not assessed in 
this study based on frequency of consumption and excessive sodium content that included: 1) 
quantity of sodium consumed while eating out, 2) strategies to reduce sodium while eating out, 
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3) choosing the best (lowest-sodium) options among unprocessed/partially-processed/fully-
processed foods, 4) low-sodium cooking strategies, 5) ultra-processed food consumption, and 6) 
the proportion of sodium that foods will contribute to the daily sodium limit. Further work is 
needed to determine the proper quantity and type of behavioral questions to ask HD patients for 
improving low-sodium dietary adherence through educational and counseling. 
 Research from several groups, including ours, has suggested a relaxation or liberalization 
of the HD diet.57,166 Findings from this current study support this, as many of the largest 
contributors to sodium intake were also large contributors to phosphorus and potassium intake. 
This is in part due the high consumption of processed foods and animal proteins that are either 
naturally high in phosphorus and potassium or have excessive phosphorus and potassium 
additives. Based on the food patterns and behavioral challenges evidenced in this study, we 
recommend: 1) easing the dietary restrictions on phosphorus and potassium from 
unprocessed/whole foods; 2) focusing on reducing the intake of processed/ultra-processed foods; 
and 3) limit the consumption of foods purchased at restaurants. This approach is much simpler 
than the renal dietary restrictions that are typically the focus of medical nutrition therapy. Other 
literature supports this position, as dietary restrictions of phosphorus and potassium in HD 
patients have contributed to poorer nutritional status, atherogenic diets, and worse survival.197 
Conclusions 
Participants in this study reported high intakes of processed foods and frequent eating 
out, which contributed not only to excessive dietary sodium consumption, but increased 
phosphorus and potassium in the diet. Participants generally had good sodium knowledge with 
several educational deficits that appeared to contribute to consumption of some foods with high-
sodium content. However, participants also consumed certain high-sodium foods despite 
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adequate knowledge on these topics, which may indicate that behavioral strategies are also 
needed to improve these dietary patterns. Additionally, there is a dissonance between salt and 
sodium in the diet, which patients believe themselves to be mostly adherent to a low-sodium diet. 
One stark finding was that higher expectations of patients and willingness to follow these 
expectations was most predictive of dietary sodium intake, which needs further evaluation. A 
common behavioral theme was frustration with the HD diet and fluid restrictions, which may 
have contributed to the observed dietary patterns. Taken together, this data suggests that the 
focus of the renal diet should be to reduce the intake of processed foods in order to better adhere 
to a low-sodium diet and improve volume overload, as well as other clinical and patient reported 
outcomes. The behavioral instruments in this study should be evaluated as feedback tools to 
guide counseling interventions and improve dietary patterns, knowledge, and barriers to 
following a low-sodium diet in HD patients.  
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Table 5.1 Subject Demographics and Nutrient Intakes 
Variable Value 
Baseline demographics  
n 20 
Age (SD), yr 55.3 (12.3) 
BMI (SD), kg/m2 40.7 (16.6) 
Women, n (%) 9 (45%) 
Black/African American, n (%) 13 (65%) 
Diabetes, n (%) 14 (70%) 
Cardiovascular Disease, n (%) 10 (50%) 
Dietary data and IDWG  
Calories 1890 ± 603 
Calories / kg 18.0 ± 7.6 
Protein, g 74 ± 16 
Protein, g / kg 0.70 ± 0.24 
Carbohydrate, g 223 ± 84 
Fat, g 79 ± 28 
Sodium, mg 3541 ± 1220 
Sodium / Calorie 1.90 ± 0.39 
Potassium, mg 1962 ± 427 
Phosphorus, mg 1054 ± 253 
Fluid, g 1418 ± 423 
Fluid estimated IDWG, kg* 3.3 ± 1.0 
Measured IDWG, kg 3.2 ± 1.1 
* Fluid estimated IDWG is based on the following calculation: Estimated IDWG (kg) = Fluid 





Table 5.2 Food Groups/Categories Highest in Proportional Sodium Intake  

















Sandwich-type foods 16.1% 1106 ± 457 2.5 ± 0.7 468 ± 201 315 ± 185 349 ± 197 66 18 (90%) 
Refined grains 14.0% 382 ± 380 1.6 ± 0.8 234 ± 152 118 ± 133 123 ± 151 166 19 (95%) 
Prepared & processed 
foods/dishes 
10.1% 659 ± 462 2.1 ± 1.3 321 ± 233 167 ± 119 304 ± 213 69 19 (95%) 
Potatoes  7.5% 522 ± 405 1.8 ± 1.0 301 ± 164 118 ± 86 717 ± 450 65 18 (90%) 
Meats, processed  7.3% 545 ± 309 2.8 ± 1.5 255 ± 186 178 ± 122 248 ± 188 61 18 (90%) 
Meats, unprocessed  6.4% 630 ± 411 1.8 ± 0.8 338 ± 159 250 ± 103 319 ± 125 46 15 (75%) 
Egg dishes 6.0% 513 ± 449 2.2 ± 1.0 213 ± 109 208 ± 110 161 ± 106 53 13 (65%) 
Pizza 5.9% 2439 ± 2146 2.4 ± 0.3 990 ± 932 613 ± 532 888 ± 590 11 8 (40%) 
Processed snacks & 
desserts 
5.3% 504 ± 410 1.3 ± 0.7 396 ± 269 95 ± 73 178 ± 170 48 14 (85%) 
Soups & stews 5.0% 1523 ± 576 11.9 ± 17.2 222 ± 100 141 ± 86 411 ± 355 15 9 (30%) 
Cumulative Total % 83.8%   76.1% 78.2% 69.1%   
The total sodium content (mg) when aggregating the top ten non-overlapping food categories accounted for 83.8% of the cumulative 
sodium intake (mg) for all subjects. Food group categories are ordered most to least as a proportion (%) of absolute total sodium 
intake across all food items eaten (i.e. largest proportional contributors to sodium in the diet as a whole). All nutrient values reported 
as mean ± standard deviation for of the items within each food category across all subjects. For example: Sandwich-type foods 
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consisted of 16.1% of the total sodium (mg) in the diet of the 6 day recalls total across all participants. Additionally, 18 (90%) subjects 
consumed 66 sandwich-type foods with an average sodium of 1106 ± 457 mg/item. Only the highest 10 categories displayed.
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Table 5.3 Linear Regression Models 
Model  
(Predictor) B 95% CI low 95% CI high P-value R
2a 
Na intake      
SEHD -628 -1304 48 0.066 0.18 
PHDD -495 -1400 410 0.259 0.03 
RAAQ -1159 -2580 263 0.099 0.17 
RABQ -1349 -3047 349 0.107 0.16 
DSRQ* -1839 -3494 -184 0.032 0.25 
DSRQ: AT  -513 -1910 885 0.442 -0.03 
DSRQ: SN* -1424 -2335 -513 0.005 0.43 
DSRQ: PBC -1182 -3342 977 0.258 0.03 
Fluid intake      
Dietary Na* 0.521 0.222 0.820 0.002 0.395 
SEHD* -0.619 -1.062 -0.177 0.010 0.368 
PHDD -0.382 -1.055 0.291 0.242 0.035 
RAAQ -0.672 -1.907 0.563 0.253 0.041 
RABQ -0.776 -2.249 0.696 0.267 0.033 
DSRQ -0.859 -2.251 0.532 0.205 0.053 
DSRQ: AT  -0.303 -1.355 0.749 0.545 -0.046 
DSRQ: SN -0.780 -1.586 0.025 0.057 0.194 
DSRQ: PBC -0.009 -1.705 1.687 0.991 -0.077 
IDWG      
Dietary Na* 0.581 0.223 0.939 0.003 0.359 
SEHD -0.125 -0.680 0.430 0.636 -0.058 
PHDD 0.071 -0.617 0.759 0.828 -0.073 
RAAQ -0.046 -1.277 1.185 0.935 -0.099 
RABQ 0.260 -1.191 1.711 0.698 -0.083 
DSRQ -0.259 -1.689 1.172 0.702 -0.064 
DSRQ: AT  0.325 -0.691 1.342 0.502 -0.039 
DSRQ: SN -0.458 -1.318 0.402 0.271 0.023 
DSRQ: PBC -0.306 -1.941 1.328 0.692 -0.064 
Na. sodium, SEHD, Self-efficacy for the HD diet; PHDD, Problems with the HD diet; DSRQ, 
Dietary sodium restriction questionnaire; RAAQ, Renal attitudes adherence questionnaire; 
RABQ, Renal attitudes behavior questionnaire; HD, hemodialysis; AT, attitudes; SN, subjective 
norm; PBC, perceived behavioral control. 








(questions most frequently missed) 
Sodium Attitudes and  






• Bread is high in sodium (2)  
• Canned/processed vegetables are high in sodium (2) 
• Processed foods/meat are high in sodium (2) 
• 1-to-1 sodium: calorie ratio (indirect)  
• Low self-efficacy for limiting processed meat 
• Problems with salty cravings (3) 
Eating Outside 
the Home 
• Eating out can contribute to high sodium 
consumption (2) 
• Daily sodium limit, <2g per day (indirect) 
• Problems following diet while eating out (2) 
• Prefer fast/restaurant and processed foods (2) 
• Low-sodium foods do not taste good 
Participants frequently consumed refined/processed grains, processed meats, and canned vegetables, which were among the most 
frequently missed questions on the sodium knowledge questionnaire. Participants reported low self-efficacy for reducing processed 
meats and salty (high sodium) food cravings. Participants also frequently ate or purchase foods outside the home (fast food/restaurant) 
and missed questions about the contribution of eating out to sodium in the diet. Participants reported frequent problems following their 
diet while eating out and preferred fast/restaurant foods.
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Figure 5.1 Bland Altman Plot and Analysis of Actual and Estimated IDWG 
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Figure 5.1: Bland-Altman plot and analysis of the combined actual and estimated IDWG mean 
predicted by the difference (actual minus estimated IDWG). The mean difference was -0.09 kg 
(2.42 to -2.61 kg; 95% upper to lower). IDWG, interdialytic weight gain. 
 
Figure 5.2 Relationship Between Dietary Sodium Intake and IDWG 















A c tu a l ID W G
E s tim a te d  ID W G
Equation
Actual IDWG Y = 0.581*X + 1.112
Estimated IDWG Y = 0.521*X + 1.418
 
Figure 5.2: Overlaid scatter plot of actual and estimated IDWG with dietary sodium intake. The 
slopes were not significant different (p=0.788). IDWG, interdialytic weight gain.  
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CHAPTER 6: CONCLUSIONS AND FUTURE DIRECTIONS 
Finding effective strategies for reducing sodium intake in an attempt to better control 
chronic volume overload and improve cardiovascular health in hemodialysis patients remains an 
elusive goal.  Our six-month pilot study that aimed to replicate a comprehensive volume control 
strategy practiced in hemodialysis patients in Izmir, Turkey did not result in significant 
reductions in self-reported dietary sodium intake, but did result in modest reductions in estimated 
dry weight and prescribed antihypertensive medications (Chapter 3). The volume control 
protocol included three major components, including: 1) reduction in BP meds; 2) progressive 
reduction of post-dialysis weight; and 3) reduction in dietary sodium. Participants had reductions 
in markers of volume overload, and blood pressure was maintained despite a reduction in 
antihypertensive medications. A key take-away from this study was we were able to produce 
modest reductions in volume overload through progressive ultrafiltration and reduced 
antihypertensive medications, but poor adherence to dietary sodium restriction attenuated the 
magnitude of the potential benefits. We encountered numerous patient and provider barriers that 
prevented us from fully implementing the volume control protocol, especially dietary sodium 
restriction.  
Due to the ubiquitous nature of sodium in the Western diet, counseling patients to reduce 
salt intake is a significant challenge. To address this, we conducted a subsequent pilot to test the 
efficacy of providing home-delivered low-sodium meals to hemodialysis patients for 4 weeks 
(Chapter 4). The primary finding of this study was that low-sodium home-delivered meal 
provision reduced interdialytic weight gain, which was likely mediated by reductions in sodium 
intake, thirst, and xerostomia. This also led to significant reductions in chronic volume overload, 
systolic and diastolic blood pressure, despite no changes in antihypertensive medications. 
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Another notable finding was that participants had a reduction in serum phosphorus and trend for 
reduced serum potassium, despite no changes in phosphate or potassium binders. The numerical 
trends for reduced tissue sodium with reduced sodium intake should be investigated in a larger 
multi-center trial. 
We also analyzed patient’s usual dietary patterns and collected measures of sodium 
knowledge, attitudes, beliefs, and behaviors (Chapter 5). A significant finding from this analysis 
was that high consumption of ultra-processed foods and frequent eating out was a primary 
contributor to sodium, phosphorus, and potassium in the diet. We also identified dietary areas of 
educational deficits, attitudes, and behaviors that need to be investigated in larger study 
populations and interventions to improve dietary patterns of hemodialysis patients. A common 
theme of these behavioral challenges is that patients are frustrated with fluid restrictions, which 
is part of the rationale our focus on sodium restriction to reduce thirst. Given the difficulties of 
counseling patients to reduce sodium intake, the home-delivery of low-sodium meals appears to 
be a promising short-term approach to promote long-term behavior change. In patients that are 
receptive to this approach, low sodium meal provision might facilitate less medication usage and 
dialysis related symptoms. It may also promote changes in patient’s salt sensitivity and 
perception to facilitate long term behavior change. Additional studies are needed to evaluate the 
effectiveness of this approach in long-term intervention studies with more robust sample sizes, 
including evaluating effects on hard outcomes such as hospitalizations, mortality, and patient 
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APPENDIX A: Supplementary Tables 
Supplementary Table 1. Foods with Most Average Servings Eaten Per Day 
Top 
Eaten Food Categories 
Servings 
per day 
1 Loaf-type Bread and Plain Rolls - Refined Grain 1.91‡ 
2 Grains, Flour and Dry Mixes - Refined Grain 1.41‡ 
3 Sweetened Soft Drinks 1.01‡ 
4 Eggs 0.95† 
5 Butter and Other Animal Fats - Regular 0.95† 
6 Oil 0.93† 
7 Unsweetened Water 0.93† 
8 Margarine - Reduced Fat 0.89† 
9 Beef 0.87† 
10 Lean Poultry 0.85† 
11 Fresh Pork 0.77† 
12 Other Vegetables (Canned) 0.71† 
13 Cold Cuts and Sausage 0.65† 
14 Fruit excluding Citrus Fruit 0.57† 
15 Other Breads (quick breads, corn muffins, tortillas) - Refined Grain 0.56† 
16 Poultry 0.55† 
17 Fried Potatoes 0.52† 
18 Sauces and Condiments - Reduced Fat 0.46* 
19 Sweetened Fruit Drinks 0.42* 
20 Cakes, Cookies, Pies, Pastries, Danish, Doughnuts and Cobblers  0.41* 
21 White Potatoes 0.39* 
22 Grains, Flour and Dry Mixes - Whole Grain 0.36* 
23 Tomato 0.34* 
24 Sugar 0.33* 
25 Unsweetened Coffee 0.31* 





Supplementary Table 2. Most Missed Sodium Knowledge Questions 
Order 
Missed Question Correct Answer Rationale 
1 Which of these sandwich ingredients are likely high in sodium? Bread buns Bread is usually high in sodium 
2 What items from a restaurant menu should you assume are likely high in sodium? All of the above 
Most restaurant foods likely 
high in sodium 
3 Circle the items from the grocery store are normally high in sodium Bread Bread is usually high in sodium 
4 The amount of sodium that you eat every day should be less than what number? Less than 2.4g/Na/d 
Amount for daily sodium mg 
limit 
5 What is the “easiest” way to tell if a food item is relatively low in sodium? 
Compare the Na (mg) to 
calories on the nutrition label 
Easiest strategy for low-Na is 
the 1:1 kcal ratio 
6 Circle the items from the grocery store that are normally high in sodium 
Canned vegetables are high 
in sodium 
Canned vegetables are high in 
sodium 
7 Choose the item that is likely to be lower in sodium Ground pork NOT turkey bacon 
Turkey bacon is high sodium, 
ground meats are usually lower 
8 Circle the items from the grocery store that are normally high in sodium 
Canned plain fruit is NOT 
high in Na 
Canned fruit is usually low in 
sodium 
9 Which of these sandwich ingredients are likely high in sodium? Pickles Pickles are high in sodium 
10 Where does most of the sodium that people eat come from? Processed / packaged foods 
Most sodium in the diet comes 
from processed food 
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Supplementary Table 3. Self-Efficacy for Following the Hemodialysis Diet Results 
Questions Result (Mean ± SD) 
Follow the dialysis diet† 3.6 ± 1.4† 
Control salt intake* 4.2 ± 1.2* 
Limit fluid intake† 3.3 ± 1.2† 
Limit canned food 4.2 ± 1.2 
Avoid table salt* 4.5 ± 1.0* 
Limit processed meat† 3.7 ± 1.2† 
Read food labels for salt 4.1 ± 1.5 
Limit interdialytic weight gain† 3.7 ± 1.1† 
Limit salty snacks 3.8 ± 1.5 
Limit eating fast food 3.9 ± 1.6 
Liming salt intake while blue or depressed* 4.4 ± 1.0* 
Liming salt intake with a poor appetite† 3.8 ± 1.7† 
Liming salt intake on dialysis days* 4.0 ± 1.8* 
Liming salt intake on non-dialysis weekdays* 4.0 ± 1.9* 
Liming salt intake on dialysis weekend days 3.8 ± 1.9 
Participants had lowest self-efficacy for following the dialysis diet and fluid restrictions. 
Participants generally reported most self-efficacy for limiting saltshaker usage and salt intake 




Supplementary Table 4. Problems with the Hemodialysis Diet Results 
Questions Result Mean ± SD 
Appropriate foods are not available in my home. 3.5 ± 1.5 
People in my life do not support my efforts to eat a healthy diet. 4.0 ± 1.1* 
I have trouble estimating portion sizes. 3.5 ± 1.4 
I have trouble keeping tracking sodium, potassium, and phosphorus. 2.6 ± 1.5† 
It is difficult to motivate myself to eat the right foods. 3.4 ± 1.3 
I use food as a reward or treat for myself. 4.1 ± 1.1* 
It is difficult to find time to plan healthy meals for myself. 3.3 ± 1.3 
I don’t see any benefits from my efforts to follow a healthy diet. 3.6 ± 1.4 
It is difficult to shop in the grocery store for one person. 3.5 ± 1.4 
I don’t know which foods I should and should not be eating. 3.3 ± 1.4 
I have difficulty controlling my eating when I am with friends or family. 3.7 ± 1.2 
When I am very hungry, I have trouble controlling what I eat. 3.6 ± 1.1 
The dialysis diet seems too complicated. 3.3 ± 1.4 
I feel deprived when I have to restrict what I eat. 3.3 ± 1.5 
I find it difficult to select the right foods when shopping. 3.7 ± 1.3 
Sometimes I crave salty foods 2.9 ± 1.2† 
It is hard to eat a healthy diet because the nearest grocery store is too far 
away. 4.5 ± 1.0* 
Eating a healthy diet costs more than I can afford. 3.7 ± 1.2 
Grocery store has a very limited selection of food. 3.9 ± 1.2 
I do not have the time to cook healthy foods. 4.1 ± 0.9* 
Resisting salty foods where I work is difficult for me.  3.5 ± 1.0 
When I am busy or feeling overwhelmed, I find it difficult to control what I eat. 3.6 ± 1.5 
I do not cook, so I don’t have control over what’s served/how its prepared. 4.6 ± 0.8* 
The hemodialysis diet is bland and tasteless. 3.2 ± 1.7 
Sometimes I just do not have an appetite. 3.1 ± 1.2 
Sometimes I am too tired to cook. 3.2 ± 1.4 
I do not have time to cook. 4.0 ± 1.0 
Sometimes I eat the wrong foods when I feel stressed. 3.6 ± 1.4 
Time at dialysis center makes it hard to eat a healthy diet on dialysis days. 3.0 ± 1.4† 
 “Wash out” after dialysis makes it hard to eat healthy on dialysis days. 2.8 ± 1.4† 
The hemodialysis diet requires a great deal of work in preparation. 3.4 ± 1.5 
The hemodialysis diet requires extra time for shopping. 3.3 ± 1.2 
It is next to impossible to follow a hemodialysis diet when eating away 
from home, such as in restaurants or cafeterias. 2.6 ± 1.5† 
It is hard to start new dietary habits because my health changes so often. 3.8 ± 1.3 
Overall Grand Mean 3.5 ± 0.8 
Following the dialysis diet restrictions and dealing with dialysis treatments were the largest 
problems. Time, grocery store distance, cooking, and social support were least problematic. All 




Supplementary Table 5. Dietary Sodium Restriction Questionnaire Construct Results 
Questions Result Mean ± SD 
Eating a low-sodium diet will reduce my thirst 4.3 ± 0.6* 
Eating a low-sodium diet will reduce my fluid swelling 4.1 ± 0.7 
Eating a low-sodium diet will make me feel less dialysis symptoms 3.8 ± 0.8 
Eating a low-sodium diet will reduce my blood pressure 4.1 ± 0.6 
Eating a low-sodium diet will keep my heart healthy 4.1 ± 0.6 
Eating a low-sodium diet will keep me out of the hospital 4.0 ± 0.6 
How important for me to reduce my thirst? 3.8 ± 1.0 
How important for me to reduce my fluid swelling? 3.8 ± 1.1 
How is important for me to generally feel less symptoms of dialysis? 3.6 ± 1.1 
How is important for me to reduce my blood pressure? 4.0 ± 0.7 
How is important for me to keep my heart healthy? 4.1 ± 0.7 
How is important for me to keep out of the hospital? 4.4 ± 0.7* 
My doctor thinks I should follow a low-sodium diet 4.1 ± 0.8 
My dietitian thinks I should follow a low-sodium diet 4.2 ± 0.6* 
My dialysis staff thinks I should follow a low-sodium diet 4.2 ± 0.6* 
My family members think I should follow a low-sodium diet 3.8 ± 0.8 
My friends or peers think I should follow a low-sodium diet 3.5 ± 0.6 
Other patients on dialysis think I should follow a low-sodium diet 3.4 ± 0.7 
When it comes to diet, I want to do what my doctor thinks I should do 3.9 ± 0.9 
When it comes to diet, I want to do what my dietitian thinks I should do 4.1 ± 0.8 
When it comes to diet, I want to do what my dialysis staff thinks I should do 3.8 ± 0.9 
When it comes to diet, I want to do family members think I should do 3.5 ± 0.9 
When it comes to diet, I want to do what my friends/peers think I should 3.2 ± 0.9† 
I want to do what other dialysis patients think I should do (diet) 3.2 ± 1.1 
I can control how often I eat out: 3.5 ± 1.0 
I can control how often I buy high-sodium foods: 3.8 ± 1.1 
I can find and afford low-sodium foods outside the home: 3.9 ± 1.0 
I have the energy to cook low-sodium foods at home: 3.6 ± 1.2 
I have the time to prepare and/or cook low-sodium foods at home: 3.6 ± 1.1 
I can tolerate eating low-sodium foods: 4.3 ± 0.6* 
I like the taste of fast food, restaurant food, and processed food  2.4 ± 0.8† 
High-sodium foods generally taste better 2.5 ± 1.0† 
Low-sodium foods are expensive and difficult to buy 3.0 ± 1.0† 
It is too hard/takes too much energy to cook low-sodium foods: 3.9 ± 0.7 
It takes too long to cook low-sodium foods:  3.9 ± 0.7 
Low-sodium foods do not taste good 2.9 ± 1.2† 
Overall Grand Mean 3.7 ± 0.4 
Taste between low and high sodium foods was the most negative attitude theme. The most 
positive responses were 1) staying out of the hospital, 2) tolerating low-sodium foods, 3) low-
sodium diets reducing thirst, and 4) dialysis staff recommending low-sodium diets. All values 
corrected for reverse-coding. † most negative, * most positive. 
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Supplementary Table 6. Renal Adherence Attitudes Questionnaire Results 
Questions Result (Mean ± SD) 
 My diet fits easily into my present lifestyle. 4.0 ± 0.8* 
 Patients on dialysis should be able to make up their own minds 
what to eat. 3.1 ± 1.1† 
 Restricting my intake of fluid is vital for my physical well-being. 4.3 ± 0.8* 
 Having to adhere to such a strict diet prevents me from attending 
social functions. 3.7 ± 0.7† 
 I feel that the dietician places too much importance on restricting 
fluid. 3.1 ± 1.4† 
 I feel the benefits of restricting my intake of foods, e.g. fruit and 
vegetables. 3.2 ± 1.4 
 I am able to drink as much fluid today as I used to. 3.8 ± 1.0* 
 I worry a lot about having gained excessive weight (e.g. over 4 lb./2 
kg) between dialyses. 3.3 ± 1.2 
 I feel the dietician places too much importance on restricting certain 
foods. 3.4 ± 0.9 
 As time goes by, I find it easier to keep to my diet. 3.6 ± 0.8 
 I do not usually feel the benefits of keeping to such a strict diet. 3.5 ± 1.1 
 It does not worry me if I gain weight between dialysis sessions. 3.5 ± 1.0 
 I feel the benefits of restricting salt. 4.0 ± 1.1* 
 I feel better when I keep to the prescribed diet 3.6 ± 1.3 
 Having to restrict fluid prevents me from enjoying myself. 3.1 ± 1.3 
 Troubling to eat different foods to the rest of my family. 3.1 ± 1.2 
 My diet severely disrupts my life. 3.6 ± 1.0 
 My diet is costly to maintain. 3.3 ± 0.9 
 I do not allow my dietary restrictions to prevent me from 
attending social functions. 3.7 ± 1.0* 
 My family and friends are important in helping me keep to the diet. 3.6 ± 0.9 
 Breaking my diet does not have any consequences to my health. 3.7 ± 0.9 
 I feel I am unable to accept the restrictions to my life as a result of 
dialysis. 3.7 ± 1.0 
 As time goes by, I find it more difficult to keep to my diet. 3.5 ± 0.9 
 I feel guilty when I break my diet. 3.0 ± 1.2† 
 I find my diet fits easily into my life. 3.5 ± 0.9 
 I become frustrated trying to keep to such a strict diet. 3.0 ± 1.0† 
Overall Grand Mean 3.5 ± 0.6 
HD diet and fluid restrictions. Understanding how important salt and fluid restrictions are. All 




Supplementary Table 7. Renal Adherence Behaviors Questionnaire Results 
Questions Result (Mean ± SD) 
I listen to the advice of my dietician. 3.7 ± 1.2 
I have difficulty restricting my intake of beer/wine. 4.4 ± 0.8* 
There are times when I cannot resist forbidden foods. 2.6 ± 1.1† 
I bargain over food. 3.5 ± 1.0 
Breaking my diet makes no difference to my health. 4.0 ± 0.6 
I do not care what I eat when I am feeling upset. 3.6 ± 1.1 
I drink as much fluid today as I ever did. 4.0 ± 1.0 
My family help me keep to my diet. 3.5 ± 0.9 
I do not keep to my diet when eating in restaurants. 3.0 ± 0.9† 
I drink more than the recommended fluid allowance when I am upset. 3.6 ± 0.7 
I avoid foods with a high salt content. 3.7 ± 0.9 
I am careful to keep to the prescribed fluid allowance. 3.6 ± 0.8 
I drink at least 5-6 mugs of fluid daily. 3.5 ± 1.3 
I am sometimes preoccupied with food which I am not supposed 
to eat. 3.3 ± 1.0† 
I take my medication as prescribed. 4.2 ± 0.8* 
I am careful to weigh food before eating it. 1.9 ± 1.0§ 
It is difficult for me to restrict fluid during the summer. 2.5 ± 0.9† 
I weigh myself regularly. 3.4 ± 1.1 
I get away with drinking more than the recommended amount of fluid. 3.4 ± 0.9 
I decide what I eat, even if it goes against the advice of the 
dietician. 2.7 ± 1.2† 
I use salt at mealtimes. 4.3 ± 0.7* 
Overall, I restrict my potassium intake. 3.8 ± 0.8 
Overall, I restrict my salt intake. 4.3 ± 0.6* 
Overall, I take my medication. 4.0 ± 0.7* 
Overall, I keep to the recommended fluid intake. 3.7 ± 1.0 
Overall Grand Mean 3.6 ± 0.5 
Fluid restrictions, eating out, and cravings. Alcohol intake, salt intake, and taking medications. 
All values corrected for reverse-coding. † most negative, * most positive, § question removed 




Supplementary Table 8. Summary of Behavioral Challenges Across Instruments 
SEHD PHDD DSRQ RAAQ RABQ 
  Challenges   
Limiting fluid (2)   Limiting fluid (2) Limiting fluid (1) 
HD diet HD diet (2)  HD diet (3)  
High-Na foods High-Na foods (2) High-Na foods (3)   High-Na foods (3) 
Poor appetite         
 HD treatments (2)    
  Low-Na cost   
  Meal decision autonomy  
Meal decision 
autonomy 
  Confidences   
Table salt / 
saltshaker       Table salt at meals 
Reducing Na intake 
(4)       Reducing Na intake 
  Meal decision autonomy       
  Grocery store distance       
  Food as a reward       
  Time to cook       
  Social support Social support (2) Social support   
    Benefits of Low-Na (3) Benefits of Low-Na   
      Fluid importance (2)   
      Satisfaction w/ current diet   
        Limiting alcohol 
        Taking medications (2) 
There was significant overlap across instruments in negative (challenge) barriers, while there 
was less overlap in positive (confident) areas. SEHD, Self-efficacy for the hemodialysis diet; 
PHDD, Problems with the hemodialysis diet; DSRQ, Dietary sodium restriction questionnaire; 
RAAQ, Renal attitudes adherence questionnaire; RABQ, Renal attitudes behavior questionnaire; 




APPENDIX B: Data Supplements 

















APPENDIX C: NDSR Food Categories 
Major Food Categories and Example Foods: 
Sandwich-type foods 
• Hamburgers, hot dogs, sandwiches 
Refined grains 
• Wheat, rice, oats 
• Breads, pastas, and cereals 
Prepared & processed foods/dishes 
• Prepared recipes, TV-type dinners, ready to eat foods 
Potatoes  
• French fries 
Meats, unprocessed  
• Beef, lamb, pork, veal, game, poultry 
Meats, processed  
• Cold cuts and sausage 
Egg dishes 
• Cooked eggs, omelets, and egg-type dishes 
Pizza 
• All pizza type foods 
Processed snacks & desserts 
• Chips, cookies, crackers, and bars 
Soups & stews 
• All soup and stew type foods and dishes 
 
